_MEMBER_data_imp_1 - 1.8-2.2,_MEMBER_data_imp_1 - 4.5-5.5,_MEMBER_data_imp_1 - 9.0-11.0,_LogP_data_imp_1 - 1.8-2.2,_LogP_data_imp_1 - 4.5-5.5,_LogP_data_imp_1 - 9.0-11.0,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,1,1,-2.1,-2.9,-3.5,CORUM:2694,ERG-JUN-FOS DNA-protein complex,M111,3,0
1,1,1,-2.4,-2.5,-3.9,M236,PID DELTA NP63 PATHWAY,M111,3,0
1,1,1,-2.4,-2.1,-2.1,hsa04211,Longevity regulating pathway,M111,3,0
1,1,1,-6.8,-4.7,-2.4,GO:0048880,sensory system development,M111,3,0
1,1,1,-12,-8,-4.1,GO:0007167,enzyme-linked receptor protein signaling pathway,M111,3,0
1,1,1,-8.4,-6.1,-2.1,GO:0002009,morphogenesis of an epithelium,M111,3,0
1,1,1,-4.9,-3.4,-7.6,GO:0021700,developmental maturation,M111,3,0
1,1,1,-4.4,-2.7,-2.7,GO:0010721,negative regulation of cell development,M111,3,0
1,1,1,-2.5,-2.6,-2.3,GO:0050680,negative regulation of epithelial cell proliferation,M111,3,0
1,1,1,-4,-2.2,-5.4,GO:1902107,positive regulation of leukocyte differentiation,M111,3,0
1,1,1,-8.7,-6.7,-9.3,GO:0030098,lymphocyte differentiation,M111,3,0
1,1,1,-3.8,-4.3,-4.5,M7,PID FCER1 PATHWAY,M111,3,0
1,1,1,-2.8,-3.3,-2.7,GO:0060760,positive regulation of response to cytokine stimulus,M111,3,0
1,1,1,-4.6,-4.1,-6,GO:0002062,chondrocyte differentiation,M111,3,0
1,1,1,-2.3,-3.9,-3.1,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,M111,3,0
1,1,1,-2.3,-3.5,-3.2,R-HSA-4411364,Binding of TCF/LEF:CTNNB1 to target gene promoters,M111,3,0
1,1,1,-9.4,-5.4,-6.7,hsa05202,Transcriptional misregulation in cancer,M111,3,0
1,1,1,-3,-2.6,-2.5,M235,PID TCR CALCIUM PATHWAY,M111,3,0
1,1,1,-4.5,-3.8,-2.6,WP5373,Role of hypoxia angiogenesis and FGF pathway in OA chondrocyte hypertrophy,M111,3,0
1,1,1,-4.7,-3.1,-5.1,GO:0046634,regulation of alpha-beta T cell activation,M111,3,0
1,1,1,-11,-7.7,-4.8,GO:0043009,chordate embryonic development,M111,3,0
1,1,1,-3.5,-2.7,-3.3,M195,PID CMYB PATHWAY,M111,3,0
1,1,1,-4,-2.3,-2.8,GO:0007610,behavior,M111,3,0
1,1,1,-5.1,-3.6,-4.3,GO:0048736,appendage development,M111,3,0
1,1,1,-7.2,-3.1,-2.2,WP2882,Nuclear receptors meta pathway,M111,3,0
1,1,1,-10,-4.9,-5.2,hsa04380,Osteoclast differentiation,M111,3,0
1,1,1,-2.7,-2,-2.1,GO:0043535,regulation of blood vessel endothelial cell migration,M111,3,0
1,1,1,-4.9,-5.2,-5.2,M183,PID IL6 7 PATHWAY,M111,3,0
1,1,1,-5.9,-2.6,-5.7,GO:0045637,regulation of myeloid cell differentiation,M111,3,0
1,1,1,-5.2,-4.6,-3.4,GO:0050769,positive regulation of neurogenesis,M111,3,0
1,1,1,-9.3,-6.9,-4.1,GO:0007389,pattern specification process,M111,3,0
1,1,1,-5.4,-6.3,-3.1,GO:0002683,negative regulation of immune system process,M111,3,0
1,1,1,-3.5,-3.3,-3.8,GO:0140467,integrated stress response signaling,M111,3,0
1,1,1,-5.1,-2.5,-2.4,GO:0002066,columnar/cuboidal epithelial cell development,M111,3,0
1,1,1,-5.4,-4.9,-3.3,hsa05169,Epstein-Barr virus infection,M111,3,0
1,1,1,-3.7,-4.6,-3.4,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,M111,3,0
1,1,1,-2.8,-3.2,-2.6,GO:0001892,embryonic placenta development,M111,3,0
1,1,1,-3.1,-2.2,-3.6,GO:2000177,regulation of neural precursor cell proliferation,M111,3,0
1,1,1,-8,-5.8,-4.7,GO:0030900,forebrain development,M111,3,0
1,1,1,-6.3,-5.3,-6.5,GO:0071345,cellular response to cytokine stimulus,M111,3,0
1,1,1,-11,-4.6,-4.8,GO:0001568,blood vessel development,M111,3,0
1,1,1,-3.2,-3.8,-4.1,WP5098,T cell activation SARS CoV 2,M111,3,0
1,1,1,-8.2,-6.5,-8.3,GO:0010720,positive regulation of cell development,M111,3,0
1,1,1,-7.1,-5.3,-4,GO:0071559,response to transforming growth factor beta,M111,3,0
1,1,1,-2.3,-2.6,-3.8,GO:0002695,negative regulation of leukocyte activation,M111,3,0
1,1,1,-9.7,-3.9,-2.6,GO:0006366,transcription by RNA polymerase II,M111,3,0
1,1,1,-4.3,-3.5,-6.1,M290,PID IL12 STAT4 PATHWAY,M111,3,0
1,1,1,-4.1,-3.1,-2.2,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,M111,3,0
1,1,1,-2.3,-5.4,-5.8,GO:0002768,immune response-regulating cell surface receptor signaling pathway,M111,3,0
1,1,1,-12,-8.8,-9.9,GO:0001501,skeletal system development,M111,3,0
1,1,1,-3.9,-2.3,-3.3,GO:0001649,osteoblast differentiation,M111,3,0
1,1,1,-9.4,-5.8,-3.6,GO:0051960,regulation of nervous system development,M111,3,0
1,1,1,-11,-11,-14,GO:0045321,leukocyte activation,M111,3,0
1,1,1,-4.1,-3.8,-3.5,hsa05207,Chemical carcinogenesis - receptor activation,M111,3,0
1,1,1,-9.7,-6.4,-9,GO:0061448,connective tissue development,M111,3,0
1,1,1,-3,-3,-5.6,GO:0045619,regulation of lymphocyte differentiation,M111,3,0
1,1,1,-7,-4.5,-7.5,hsa05167,Kaposi sarcoma-associated herpesvirus infection,M111,3,0
1,1,1,-2.3,-2.1,-3.1,GO:0070663,regulation of leukocyte proliferation,M111,3,0
1,1,1,-3.9,-4.7,-4.1,GO:0002250,adaptive immune response,M111,3,0
1,1,1,-8.2,-4.3,-2.8,GO:1901699,cellular response to nitrogen compound,M111,3,0
1,1,1,-13,-5.1,-4.2,GO:1902893,regulation of miRNA transcription,M111,3,0
1,1,1,-2.3,-2.3,-2.3,GO:0001890,placenta development,M111,3,0
1,1,1,-8,-5,-5.7,GO:0021537,telencephalon development,M111,3,0
1,1,1,-4.4,-5.2,-6.1,GO:0045664,regulation of neuron differentiation,M111,3,0
1,1,1,-2.2,-2.4,-2.3,WP3995,Prion disease pathway,M111,3,0
1,1,1,-4.3,-4.7,-6.3,GO:0002694,regulation of leukocyte activation,M111,3,0
1,1,1,-4.6,-3.5,-4,M272,PID CD8 TCR DOWNSTREAM PATHWAY,M111,3,0
1,1,1,-6,-5.9,-3.6,GO:0001819,positive regulation of cytokine production,M111,3,0
1,1,1,-2.7,-2.4,-4.2,R-HSA-983705,Signaling by the B Cell Receptor (BCR),M111,3,0
1,1,1,-3.5,-5.4,-5.2,GO:0042472,inner ear morphogenesis,M111,3,0
1,1,1,-11,-6,-3.4,GO:0045596,negative regulation of cell differentiation,M111,3,0
1,1,1,-4.5,-5.1,-4.5,GO:0048706,embryonic skeletal system development,M111,3,0
1,1,1,-7.7,-2.4,-2,GO:1901652,response to peptide,M111,3,0
1,1,1,-4,-4.8,-2.9,GO:0055123,digestive system development,M111,3,0
1,1,1,-3.4,-4.5,-2.3,GO:0021988,olfactory lobe development,M111,3,0
1,1,1,-2.6,-5.4,-4.1,GO:0021872,forebrain generation of neurons,M111,3,0
1,1,1,-4,-4,-4.2,M10,PID BCR 5PATHWAY,M111,3,0
1,1,1,-6.3,-2.6,-3.6,WP706,Sudden infant death syndrome SIDS susceptibility pathways,M111,3,0
1,1,1,-7.5,-3.4,-4.1,GO:0061061,muscle structure development,M111,3,0
1,1,1,-3.6,-2.9,-2.6,WP4816,TGF beta receptor signaling in skeletal dysplasias,M111,3,0
1,1,1,-2.5,-3.5,-2,GO:0042475,odontogenesis of dentin-containing tooth,M111,3,0
1,1,1,-7.4,-4.2,-9.3,GO:1903706,regulation of hemopoiesis,M111,3,0
1,1,1,-2.1,-2,-2.9,GO:0090103,cochlea morphogenesis,M111,3,0
1,1,1,-8.1,-6.1,-3.7,GO:0050767,regulation of neurogenesis,M111,3,0
1,1,1,-3,-3.1,-4.1,hsa05215,Prostate cancer,M111,3,0
1,1,1,-7.7,-3.8,-5.5,GO:0048705,skeletal system morphogenesis,M111,3,0
1,1,1,-3.4,-2.3,-2.4,GO:1902692,regulation of neuroblast proliferation,M111,3,0
1,1,1,-10,-3.6,-4,GO:0045444,fat cell differentiation,M111,3,0
1,1,1,-10,-9.5,-14,GO:0046649,lymphocyte activation,M111,3,0
1,1,1,-2.1,-3.7,-2,GO:0002053,positive regulation of mesenchymal cell proliferation,M111,3,0
1,1,1,-12,-5.7,-3.9,GO:2000628,regulation of miRNA metabolic process,M111,3,0
1,1,1,-12,-7,-4.3,GO:0035239,tube morphogenesis,M111,3,0
1,1,1,-8.8,-5.3,-3.2,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,M111,3,0
1,1,1,-9.2,-4.7,-6.5,GO:0061351,neural precursor cell proliferation,M111,3,0
1,1,1,-3.6,-4.7,-2.4,GO:0021772,olfactory bulb development,M111,3,0
1,1,1,-2.9,-2,-2,M36,PID IL27 PATHWAY,M111,3,0
1,1,1,-4.3,-6.2,-3.4,GO:0006954,inflammatory response,M111,3,0
1,1,1,-7.9,-3.2,-2.6,GO:0006351,DNA-templated transcription,M111,3,0
1,1,1,-7.8,-4.1,-3.3,GO:0048514,blood vessel morphogenesis,M111,3,0
1,1,1,-2.5,-3.7,-4,WP69,T cell receptor signaling pathway,M111,3,0
1,1,1,-6.2,-4.1,-3.3,GO:0051962,positive regulation of nervous system development,M111,3,0
1,1,1,-5.6,-5.7,-8,WP23,B cell receptor signaling pathway,M111,3,0
1,1,1,-2.8,-4.8,-5.1,GO:0022409,positive regulation of cell-cell adhesion,M111,3,0
1,1,1,-2.1,-2.9,-3.5,CORUM:2695,ETS2-FOS-JUN complex,M111,3,0
1,1,1,-9.7,-2.2,-5.9,WP236,Adipogenesis,M111,3,0
1,1,1,-11,-8.2,-8.4,GO:0008283,cell population proliferation,M111,3,0
1,1,1,-3.9,-4.6,-4.9,GO:0043583,ear development,M111,3,0
1,1,1,-4.4,-4.5,-3.1,GO:0048565,digestive tract development,M111,3,0
1,1,1,-11,-4.9,-2.4,hsa05166,Human T-cell leukemia virus 1 infection,M111,3,0
1,1,1,-3.4,-3.5,-2.1,R-HSA-8951671,RUNX3 regulates YAP1-mediated transcription,M111,3,0
1,1,1,-10,-6.5,-4.8,GO:0007420,brain development,M111,3,0
1,1,1,-2.5,-2.5,-2.4,GO:0050890,cognition,M111,3,0
1,1,1,-4.8,-3.7,-5.6,GO:0042063,gliogenesis,M111,3,0
1,1,1,-10,-6.2,-7.4,GO:0042110,T cell activation,M111,3,0
1,1,1,-6.4,-6.8,-7.2,GO:0051216,cartilage development,M111,3,0
1,1,1,-5.1,-3.6,-4.3,GO:0060173,limb development,M111,3,0
1,1,1,-7.5,-4.4,-5.1,GO:0030217,T cell differentiation,M111,3,0
1,1,1,-5.7,-3,-2.5,GO:0035914,skeletal muscle cell differentiation,M111,3,0
1,1,1,-10,-7.7,-6.8,M167,PID AP1 PATHWAY,M111,3,0
1,1,1,-3.2,-4.1,-5.4,hsa05221,Acute myeloid leukemia,M111,3,0
1,1,1,-2.1,-3.3,-2.7,GO:0032943,mononuclear cell proliferation,M111,3,0
1,1,1,-2.1,-2.9,-3.5,CORUM:2693,NFAT-JUN-FOS DNA-protein complex,M111,3,0
1,1,1,-2.3,-4.9,-2.1,M26,PID NFKAPPAB ATYPICAL PATHWAY,M111,3,0
1,1,1,-5.6,-6.5,-5.7,GO:0050678,regulation of epithelial cell proliferation,M111,3,0
1,1,1,-3.6,-3.8,-2.3,WP3929,Chemokine signaling pathway,M111,3,0
1,1,1,-2.4,-3,-3.1,GO:0043584,nose development,M111,3,0
1,1,1,-13,-4.9,-4.1,GO:0140747,regulation of ncRNA transcription,M111,3,0
1,1,1,-8.1,-9.6,-6.1,GO:0048562,embryonic organ morphogenesis,M111,3,0
1,1,1,-7.6,-2.1,-2.1,WP3646,Hepatitis C and hepatocellular carcinoma,M111,3,0
1,1,1,-9.6,-12,-6,GO:0070848,response to growth factor,M111,3,0
1,1,1,-2.5,-3.9,-4.8,GO:0048663,neuron fate commitment,M111,3,0
1,1,1,-2.1,-3.3,-2.7,GO:0046651,lymphocyte proliferation,M111,3,0
1,1,1,-9,-7.6,-4.9,GO:0007423,sensory organ development,M111,3,0
1,1,1,-11,-4.6,-6.9,WP4149,White fat cell differentiation,M111,3,0
1,1,1,-3.8,-2.2,-4.6,GO:0046635,positive regulation of alpha-beta T cell activation,M111,3,0
1,1,1,-11,-5.5,-5.2,GO:0060322,head development,M111,3,0
1,1,1,-7.4,-2.8,-2.9,GO:0031348,negative regulation of defense response,M111,3,0
1,1,1,-4.7,-2.8,-2.1,GO:0014013,regulation of gliogenesis,M111,3,0
1,1,1,-3.8,-2.4,-6.7,GO:0030218,erythrocyte differentiation,M111,3,0
1,1,1,-7.8,-5.7,-3.7,GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,M111,3,0
1,1,1,-7.7,-4.7,-12,GO:0030099,myeloid cell differentiation,M111,3,0
1,1,1,-4.9,-3,-2.5,M54,PID IL12 2PATHWAY,M111,3,0
1,1,1,-5,-3.4,-5,GO:0002573,myeloid leukocyte differentiation,M111,3,0
1,1,1,-4.1,-5.3,-2.9,GO:0061138,morphogenesis of a branching epithelium,M111,3,0
1,1,1,-4.1,-2.7,-4.1,hsa04928,"Parathyroid hormone synthesis, secretion and action",M111,3,0
1,1,1,-3.7,-2.2,-3.5,GO:0090102,cochlea development,M111,3,0
1,1,1,-3.2,-2.2,-4.2,GO:0021781,glial cell fate commitment,M111,3,0
1,1,1,-4.6,-7.1,-3.2,GO:0030509,BMP signaling pathway,M111,3,0
1,1,1,-8.8,-6.1,-4,GO:2000630,positive regulation of miRNA metabolic process,M111,3,0
1,1,1,-5.3,-2.7,-3.8,GO:0046631,alpha-beta T cell activation,M111,3,0
1,1,1,-4.1,-2.6,-2.5,WP1528,Physiological and pathological hypertrophy of the heart,M111,3,0
1,1,1,-7.1,-4.6,-5.2,WP2849,Hematopoietic stem cell differentiation,M111,3,0
1,1,1,-4.3,-2.6,-2.8,WP363,Wnt signaling pathway,M111,3,0
1,1,1,-8.6,-5.5,-3.4,GO:0003002,regionalization,M111,3,0
1,1,1,-5,-3.1,-3,GO:0001764,neuron migration,M111,3,0
1,1,1,-2.4,-4.2,-4.4,GO:0045580,regulation of T cell differentiation,M111,3,0
1,1,1,-11,-7.8,-4.7,GO:0009792,embryo development ending in birth or egg hatching,M111,3,0
1,1,1,-3.4,-3.4,-2.2,GO:0048638,regulation of developmental growth,M111,3,0
1,1,1,-3.6,-4.3,-3.2,GO:0002252,immune effector process,M111,3,0
1,1,1,-3.8,-3,-3.3,WP437,EGF EGFR signaling pathway,M111,3,0
1,1,1,-4,-3.1,-4.3,GO:0072089,stem cell proliferation,M111,3,0
1,1,1,-3.2,-3.1,-2.6,GO:0021675,nerve development,M111,3,0
1,1,1,-3.8,-2.7,-2.5,GO:0045665,negative regulation of neuron differentiation,M111,3,0
1,1,1,-2.3,-3.2,-3.6,M122,PID IL2 1PATHWAY,M111,3,0
1,1,1,-4.4,-2.7,-2.2,GO:0007519,skeletal muscle tissue development,M111,3,0
1,1,1,-6,-3.2,-3.3,GO:0030879,mammary gland development,M111,3,0
1,1,1,-5.6,-5,-3.3,GO:0048844,artery morphogenesis,M111,3,0
1,1,1,-2,-4.6,-2.3,GO:0032663,regulation of interleukin-2 production,M111,3,0
1,1,1,-8.8,-5.4,-3.5,GO:0008285,negative regulation of cell population proliferation,M111,3,0
1,1,1,-4.7,-4.1,-4.4,GO:0050867,positive regulation of cell activation,M111,3,0
1,1,1,-2.6,-4.9,-4.7,GO:0002764,immune response-regulating signaling pathway,M111,3,0
1,1,1,-3.6,-3.3,-2.3,GO:0051101,regulation of DNA binding,M111,3,0
1,1,1,-3.8,-2.5,-3.3,GO:0048483,autonomic nervous system development,M111,3,0
1,1,1,-2.2,-2.7,-3,GO:0051250,negative regulation of lymphocyte activation,M111,3,0
1,1,1,-6,-8.3,-2.7,GO:0003151,outflow tract morphogenesis,M111,3,0
1,1,1,-4,-2.2,-5.4,GO:1903708,positive regulation of hemopoiesis,M111,3,0
1,1,1,-3.9,-2,-2.5,GO:0031343,positive regulation of cell killing,M111,3,0
1,1,1,-4.1,-3,-2.3,GO:0060443,mammary gland morphogenesis,M111,3,0
1,1,1,-7.7,-3.4,-2.3,GO:0002065,columnar/cuboidal epithelial cell differentiation,M111,3,0
1,1,1,-3.8,-2.2,-6.2,GO:0034101,erythrocyte homeostasis,M111,3,0
1,1,1,-8.8,-6.3,-3.6,GO:0030855,epithelial cell differentiation,M111,3,0
1,1,1,-3.6,-5.6,-2.6,hsa05321,Inflammatory bowel disease,M111,3,0
1,1,1,-6,-5.5,-2.1,GO:0060562,epithelial tube morphogenesis,M111,3,0
1,1,1,-2.8,-2.3,-2.5,GO:0035115,embryonic forelimb morphogenesis,M111,3,0
1,1,1,-4.3,-4.7,-3.5,GO:0050778,positive regulation of immune response,M111,3,0
1,1,1,-5,-4.5,-2.1,R-HSA-8878166,Transcriptional regulation by RUNX2,M111,3,0
1,1,1,-3.8,-5.6,-4.4,GO:0042471,ear morphogenesis,M111,3,0
1,1,1,-4.5,-4.1,-4.7,GO:0010001,glial cell differentiation,M111,3,0
1,1,1,-3,-2.7,-4,WP4844,Influence of laminopathies on Wnt signaling,M111,3,0
1,1,1,-3.7,-3.9,-3.6,R-HSA-8878159,Transcriptional regulation by RUNX3,M111,3,0
1,1,1,-4.8,-3.9,-2.5,GO:0007498,mesoderm development,M111,3,0
1,1,1,-3.8,-3.1,-2,GO:0003013,circulatory system process,M111,3,0
1,1,1,-5.1,-2.3,-2.4,GO:0002819,regulation of adaptive immune response,M111,3,0
1,1,1,-2.4,-2.6,-3.3,GO:2000106,regulation of leukocyte apoptotic process,M111,3,0
1,1,1,-6.3,-3.5,-4.6,GO:0021543,pallium development,M111,3,0
1,1,1,-3.2,-2.3,-2.2,GO:0061371,determination of heart left/right asymmetry,M111,3,0
1,1,1,-4.2,-2.4,-6.7,hsa04662,B cell receptor signaling pathway,M111,3,0
1,1,1,-3.3,-3.9,-2.4,GO:0051090,regulation of DNA-binding transcription factor activity,M111,3,0
1,1,1,-6,-4.3,-3.9,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,M111,3,0
1,1,1,-4.9,-3,-6.7,GO:0071695,anatomical structure maturation,M111,3,0
1,1,1,-5.6,-3.2,-6.2,GO:0060021,roof of mouth development,M111,3,0
1,1,1,-2.6,-3.6,-3.7,GO:0021954,central nervous system neuron development,M111,3,0
1,1,1,-8.5,-4.6,-3,GO:0071417,cellular response to organonitrogen compound,M111,3,0
1,1,1,-12,-3.5,-2.9,GO:0009725,response to hormone,M111,3,0
1,1,1,-2.8,-2.7,-5.1,GO:0021892,cerebral cortex GABAergic interneuron differentiation,M111,3,0
1,1,1,-2.7,-2.8,-3.9,GO:0045621,positive regulation of lymphocyte differentiation,M111,3,0
1,1,1,-8.3,-11,-5.3,GO:0071363,cellular response to growth factor stimulus,M111,3,0
1,1,1,-6.4,-2.9,-7.6,GO:1902105,regulation of leukocyte differentiation,M111,3,0
1,1,1,-2.1,-3.6,-2.7,GO:0050679,positive regulation of epithelial cell proliferation,M111,3,0
1,1,1,-5.4,-2.8,-3.1,M2,PID SMAD2 3NUCLEAR PATHWAY,M111,3,0
1,1,1,-4.6,-3.2,-4.2,GO:1902075,cellular response to salt,M111,3,0
1,1,1,-2.7,-4.3,-3.4,WP5198,Inflammatory bowel disease signaling,M111,3,0
1,1,1,-11,-7.2,-12,GO:1903131,mononuclear cell differentiation,M111,3,0
1,1,1,-7.3,-5.2,-3.5,GO:0001701,in utero embryonic development,M111,3,0
1,1,1,-4.3,-4.1,-2.9,GO:0002263,cell activation involved in immune response,M111,3,0
1,1,1,-8.1,-3.8,-3.3,WP366,TGF beta signaling pathway,M111,3,0
1,1,1,-9.6,-5.5,-3.1,GO:0048732,gland development,M111,3,0
1,1,1,-2.2,-3.5,-3.3,GO:0002274,myeloid leukocyte activation,M111,3,0
1,1,1,-2.6,-2.9,-5.5,GO:0045646,regulation of erythrocyte differentiation,M111,3,0
1,1,1,-2.7,-2.4,-4.5,WP3599,Transcription factor regulation in adipogenesis,M111,3,0
1,1,1,-3,-3.9,-5.2,WP5293,Acute myeloid leukemia,M111,3,0
1,1,1,-2.2,-2.6,-2.5,GO:0021846,cell proliferation in forebrain,M111,3,0
1,1,1,-6.3,-4.5,-3.1,GO:0071560,cellular response to transforming growth factor beta stimulus,M111,3,0
1,1,1,-5.9,-2,-4,WP4211,Transcriptional cascade regulating adipogenesis,M111,3,0
1,1,1,-4.2,-4.9,-2.6,GO:0035050,embryonic heart tube development,M111,3,0
1,1,1,-2.8,-4.6,-5.6,GO:1903039,positive regulation of leukocyte cell-cell adhesion,M111,3,0
1,1,1,-3.7,-2.2,-3.3,WP5083,Neuroinflammation and glutamatergic signaling,M111,3,0
1,1,1,-4.7,-4,-5.1,GO:0051251,positive regulation of lymphocyte activation,M111,3,0
1,1,1,-4.3,-4.1,-5.2,GO:0035107,appendage morphogenesis,M111,3,0
1,1,1,-4.6,-4.8,-2.5,WP4659,Gastrin signaling pathway,M111,3,0
1,1,1,-3.5,-3.6,-4.9,GO:0048872,homeostasis of number of cells,M111,3,0
1,1,1,-12,-12,-8.9,GO:0048568,embryonic organ development,M111,3,0
1,1,1,-2.6,-3.3,-2.4,R-HSA-9006925,Intracellular signaling by second messengers,M111,3,0
1,1,1,-6,-7.3,-2.4,WP2840,Hair follicle development cytodifferentiation part 3 of 3,M111,3,0
1,1,1,-8,-6.8,-4.4,hsa05200,Pathways in cancer,M111,3,0
1,1,1,-6,-8.7,-3.2,GO:0071772,response to BMP,M111,3,0
1,1,1,-3.8,-3,-7,GO:0045639,positive regulation of myeloid cell differentiation,M111,3,0
1,1,1,-7,-3.6,-5.5,R-HSA-9616222,Transcriptional regulation of granulopoiesis,M111,3,0
1,1,1,-3.4,-3.6,-3,WP5130,Th17 cell differentiation pathway,M111,3,0
1,1,1,-4.3,-4.1,-5.2,GO:0035108,limb morphogenesis,M111,3,0
1,1,1,-10,-7.5,-2.2,GO:0048729,tissue morphogenesis,M111,3,0
1,1,1,-8.6,-4.8,-6.6,R-HSA-449147,Signaling by Interleukins,M111,3,0
1,1,1,-4,-4.7,-5.8,GO:0048839,inner ear development,M111,3,0
1,1,1,-6.1,-5.2,-4.5,GO:0007405,neuroblast proliferation,M111,3,0
1,1,1,-3.8,-2.7,-3.1,R-HSA-2559583,Cellular Senescence,M111,3,0
1,1,1,-2.8,-3.9,-2.5,GO:0021895,cerebral cortex neuron differentiation,M111,3,0
1,1,1,-10,-4.3,-4.5,GO:0001944,vasculature development,M111,3,0
1,1,1,-2.4,-4.2,-2.8,GO:0032655,regulation of interleukin-12 production,M111,3,0
1,1,1,-3.5,-4.5,-2.7,GO:0045666,positive regulation of neuron differentiation,M111,3,0
1,1,1,-4.1,-3.2,-3.5,GO:0001708,cell fate specification,M111,3,0
1,1,1,-4,-5.4,-4,GO:0021953,central nervous system neuron differentiation,M111,3,0
1,1,1,-2.1,-2,-2,GO:0048486,parasympathetic nervous system development,M111,3,0
1,1,1,-5.9,-3.9,-3.8,GO:0007517,muscle organ development,M111,3,0
1,1,1,-2,-2.6,-3.5,GO:0070665,positive regulation of leukocyte proliferation,M111,3,0
1,1,1,-3.9,-4.6,-6.4,GO:0051249,regulation of lymphocyte activation,M111,3,0
1,1,1,-12,-8.1,-14,GO:0002521,leukocyte differentiation,M111,3,0
1,1,1,-4.2,-3.9,-2.9,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",M111,3,0
1,1,1,-2.6,-3.9,-2.1,hsa04062,Chemokine signaling pathway,M111,3,0
1,1,1,-3.2,-2.9,-2.2,GO:0001961,positive regulation of cytokine-mediated signaling pathway,M111,3,0
1,1,1,-5.4,-3.1,-4.5,GO:0048704,embryonic skeletal system morphogenesis,M111,3,0
1,1,1,-4.2,-2.2,-2.2,WP3972,PDGFR beta pathway,M111,3,0
1,1,1,-3.2,-2.2,-2.6,GO:0051098,regulation of binding,M111,3,0
1,1,1,-4.5,-5,-2.3,WP2064,Neural crest differentiation,M111,3,0
1,1,1,-2.5,-3.8,-3.1,GO:0070661,leukocyte proliferation,M111,3,0
1,1,1,-4.4,-3.2,-3.4,GO:0050727,regulation of inflammatory response,M111,3,0
1,1,1,-3.8,-2.4,-2.7,WP560,TGF beta receptor signaling,M111,3,0
1,1,1,-2.8,-4.9,-3.4,GO:0010464,regulation of mesenchymal cell proliferation,M111,3,0
1,1,1,-6.6,-3.9,-2.1,GO:0060537,muscle tissue development,M111,3,0
1,1,1,-9.5,-5.4,-4.4,GO:1902895,positive regulation of miRNA transcription,M111,3,0
1,1,1,-6.4,-3.1,-7.3,GO:0048469,cell maturation,M111,3,0
1,1,1,-2.9,-3.4,-4.2,GO:0050870,positive regulation of T cell activation,M111,3,0
1,1,1,-4.1,-4.3,-5.7,GO:0035113,embryonic appendage morphogenesis,M111,3,0
1,1,1,-4.3,-4.1,-2.9,GO:0002366,leukocyte activation involved in immune response,M111,3,0
1,1,1,-4.5,-4.4,-2.5,GO:0090596,sensory organ morphogenesis,M111,3,0
1,1,1,-6,-8.7,-3.2,GO:0071773,cellular response to BMP stimulus,M111,3,0
1,1,1,-4.6,-4.8,-6.3,GO:0045785,positive regulation of cell adhesion,M111,3,0
1,1,1,-2.8,-4,-2.3,GO:0055057,neuroblast division,M111,3,0
1,1,1,-6.2,-6,-3.6,hsa04659,Th17 cell differentiation,M111,3,0
1,1,1,-4,-3.5,-3.6,GO:0001503,ossification,M111,3,0
1,1,1,-3.9,-2.6,-3.4,GO:0021987,cerebral cortex development,M111,3,0
1,1,1,-6.6,-4,-2.9,GO:0060840,artery development,M111,3,0
1,1,1,-3.4,-4.6,-2.2,GO:0048754,branching morphogenesis of an epithelial tube,M111,3,0
1,1,1,-4.4,-5.8,-2.1,WP3527,Pre implantation embryo,M111,3,0
1,1,1,-3.3,-3.5,-3.5,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",M111,3,0
1,1,1,-4.6,-6.3,-4.1,GO:0001763,morphogenesis of a branching structure,M111,3,0
1,1,1,-5.8,-8.3,-2.3,GO:0048863,stem cell differentiation,M111,3,0
1,1,1,-12,-14,-7.9,GO:0045165,cell fate commitment,M111,3,0
1,1,1,-2.1,-2.7,-2.1,GO:0008593,regulation of Notch signaling pathway,M111,3,0
1,1,1,-4.8,-3.7,-3.8,M60,PID NFAT TFPATHWAY,M111,3,0
1,1,1,-3.5,-3.9,-5.2,GO:0097154,GABAergic neuron differentiation,M111,3,0
1,1,1,-9.8,-10,-14,GO:0001775,cell activation,M111,3,0
1,1,1,-2,-2.6,-3.3,M186,PID PDGFRB PATHWAY,M111,3,0
1,1,1,-2.9,-2.1,-4.2,GO:0060872,semicircular canal development,M111,3,0
1,1,1,-2.4,-3,-4,GO:0045582,positive regulation of T cell differentiation,M111,3,0
1,1,1,-3.2,-2,-4.1,GO:0021795,cerebral cortex cell migration,M111,3,0
1,1,1,-3,-3.1,-2.8,GO:0060541,respiratory system development,M111,3,0
1,1,1,-4.5,-2.3,-3.7,GO:0048701,embryonic cranial skeleton morphogenesis,M111,3,0
1,1,1,-7.1,-4.8,-2.4,GO:0150063,visual system development,M111,3,0
1,1,1,-4.1,-4.3,-5.7,GO:0030326,embryonic limb morphogenesis,M111,3,0
1,1,1,-3.4,-2.4,-2.3,GO:0001947,heart looping,M111,3,0
1,1,1,-8.1,-3.1,-2.5,GO:0032774,RNA biosynthetic process,M111,3,0
1,1,1,-8,-4.6,-4.9,R-HSA-1280215,Cytokine Signaling in Immune system,M111,3,0
1,1,1,-7,-2.3,-3.3,GO:1904888,cranial skeletal system development,M111,3,0
1,1,1,-4.5,-4.3,-4.8,GO:0002696,positive regulation of leukocyte activation,M111,3,0
1,1,1,-3.2,-3,-3.1,R-HSA-2871796,FCERI mediated MAPK activation,M111,3,0
1,1,1,-3,-8.3,-4,hsa04658,Th1 and Th2 cell differentiation,M111,3,0
1,1,1,-4.4,-2.5,-2,GO:0060538,skeletal muscle organ development,M111,3,0
1,1,1,-2.9,-3.2,-2.9,R-HSA-8951430,RUNX3 regulates WNT signaling,M111,3,0
1,1,1,-5,-3.8,-4.7,GO:0046637,regulation of alpha-beta T cell differentiation,M111,3,0
1,1,1,-11,-10,-5.3,GO:0048598,embryonic morphogenesis,M111,3,0
1,1,1,-2.4,-2.2,-2.2,GO:0021783,preganglionic parasympathetic fiber development,M111,3,0
1,1,1,-14,-9.8,-18,GO:0030097,hemopoiesis,M111,3,0
1,1,0,-5.4,-3.9,0,GO:0060037,pharyngeal system development,M110,2,0
0,1,1,0,-3.1,-2,GO:0002443,leukocyte mediated immunity,M011,2,0
1,0,1,-2.6,0,-4.9,WP5102,Familial partial lipodystrophy,M101,2,0
1,0,1,-2.5,0,-3.9,hsa05417,Lipid and atherosclerosis,M101,2,0
1,1,0,-4.1,-2.6,0,GO:2001053,regulation of mesenchymal cell apoptotic process,M110,2,0
1,1,0,-4.6,-2,0,GO:0060395,SMAD protein signal transduction,M110,2,0
0,1,1,0,-3.9,-3.3,GO:0022604,regulation of cell morphogenesis,M011,2,0
0,1,1,0,-3.7,-3.6,GO:0050851,antigen receptor-mediated signaling pathway,M011,2,0
1,1,0,-7.1,-4.7,0,GO:0043010,camera-type eye development,M110,2,0
1,1,0,-4,-2.3,0,GO:0002292,T cell differentiation involved in immune response,M110,2,0
0,1,1,0,-2.4,-2.8,GO:0038093,Fc receptor signaling pathway,M011,2,0
1,1,0,-2.2,-2.4,0,GO:0045599,negative regulation of fat cell differentiation,M110,2,0
1,0,1,-2.3,0,-6.1,R-HSA-9664407,Parasite infection,M101,2,0
1,1,0,-3.4,-2,0,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",M110,2,0
1,1,0,-3,-3.2,0,WP1544,MicroRNAs in cardiomyocyte hypertrophy,M110,2,0
1,1,0,-4.8,-4.6,0,GO:0032102,negative regulation of response to external stimulus,M110,2,0
1,1,0,-2.6,-3.1,0,WP474,Endochondral ossification,M110,2,0
1,1,0,-6.1,-2.6,0,GO:0031341,regulation of cell killing,M110,2,0
1,1,0,-2.4,-2.2,0,R-HSA-9823730,Formation of definitive endoderm,M110,2,0
1,0,1,-2.6,0,-3.7,GO:0048709,oligodendrocyte differentiation,M101,2,0
1,0,1,-2.6,0,-2.6,R-HSA-9679191,Potential therapeutics for SARS,M101,2,0
0,1,1,0,-4,-3.4,GO:0051345,positive regulation of hydrolase activity,M011,2,0
1,1,0,-6.7,-4.7,0,GO:0001654,eye development,M110,2,0
1,1,0,-2.9,-4.4,0,WP4337,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma,M110,2,0
1,1,0,-2.2,-2.5,0,hsa04919,Thyroid hormone signaling pathway,M110,2,0
1,1,0,-2.4,-2.2,0,GO:0071248,cellular response to metal ion,M110,2,0
1,1,0,-3,-3.4,0,GO:1904018,positive regulation of vasculature development,M110,2,0
1,1,0,-2.4,-2.6,0,GO:0032835,glomerulus development,M110,2,0
0,1,1,0,-2.2,-2.6,WP2380,Brain derived neurotrophic factor BDNF signaling pathway,M011,2,0
1,0,1,-6.3,0,-2.2,hsa05163,Human cytomegalovirus infection,M101,2,0
1,1,0,-6.2,-2.2,0,GO:0009952,anterior/posterior pattern specification,M110,2,0
0,1,1,0,-4.6,-5.3,GO:0002429,immune response-activating cell surface receptor signaling pathway,M011,2,0
1,1,0,-3.8,-3.1,0,GO:0061180,mammary gland epithelium development,M110,2,0
1,1,0,-3.1,-2.1,0,GO:0035710,"CD4-positive, alpha-beta T cell activation",M110,2,0
1,0,1,-2.8,0,-2.3,GO:0060135,maternal process involved in female pregnancy,M101,2,0
1,1,0,-2.9,-3.1,0,GO:0045787,positive regulation of cell cycle,M110,2,0
1,1,0,-2.9,-2.8,0,GO:0001657,ureteric bud development,M110,2,0
1,1,0,-5.4,-2.8,0,GO:0046632,alpha-beta T cell differentiation,M110,2,0
0,1,1,0,-4.4,-6.6,GO:0030183,B cell differentiation,M011,2,0
1,1,0,-2.8,-4.2,0,M164,PID ERBB1 DOWNSTREAM PATHWAY,M110,2,0
1,1,0,-2.3,-4.2,0,WP2324,AGE RAGE pathway,M110,2,0
0,1,1,0,-2.4,-2.1,GO:0098543,detection of other organism,M011,2,0
1,1,0,-4.1,-3.2,0,hsa04550,Signaling pathways regulating pluripotency of stem cells,M110,2,0
1,1,0,-2.9,-2.4,0,GO:0051147,regulation of muscle cell differentiation,M110,2,0
1,0,1,-3.6,0,-2.1,hsa05170,Human immunodeficiency virus 1 infection,M101,2,0
1,1,0,-2.4,-2.1,0,hsa04933,AGE-RAGE signaling pathway in diabetic complications,M110,2,0
1,1,0,-4.2,-2.3,0,GO:0002704,negative regulation of leukocyte mediated immunity,M110,2,0
1,0,1,-3,0,-2.5,M241,PID RAC1 REG PATHWAY,M101,2,0
1,1,0,-3,-2,0,GO:0001667,ameboidal-type cell migration,M110,2,0
1,1,0,-2.5,-2.1,0,GO:0010634,positive regulation of epithelial cell migration,M110,2,0
1,0,1,-2.1,0,-2,R-HSA-114604,GPVI-mediated activation cascade,M101,2,0
1,1,0,-4.1,-3.1,0,GO:0071383,cellular response to steroid hormone stimulus,M110,2,0
0,1,1,0,-2.4,-4.5,WP3892,Development of pulmonary dendritic cells and macrophage subsets,M011,2,0
1,1,0,-4.7,-3.6,0,GO:0007369,gastrulation,M110,2,0
1,1,0,-2.6,-2.6,0,GO:2000178,negative regulation of neural precursor cell proliferation,M110,2,0
1,0,1,-2.5,0,-4.8,hsa04725,Cholinergic synapse,M101,2,0
1,1,0,-2.8,-3,0,GO:0060795,cell fate commitment involved in formation of primary germ layer,M110,2,0
1,1,0,-9.6,-5,0,GO:0032870,cellular response to hormone stimulus,M110,2,0
1,1,0,-2.5,-2.9,0,GO:0032729,positive regulation of type II interferon production,M110,2,0
1,1,0,-2.8,-2.5,0,GO:0003197,endocardial cushion development,M110,2,0
1,0,1,-2.3,0,-6.1,R-HSA-9664422,FCGR3A-mediated phagocytosis,M101,2,0
1,1,0,-4.3,-3.9,0,GO:0045667,regulation of osteoblast differentiation,M110,2,0
1,0,1,-2.5,0,-3.2,GO:1900015,regulation of cytokine production involved in inflammatory response,M101,2,0
1,1,0,-3.5,-2.1,0,GO:1903530,regulation of secretion by cell,M110,2,0
1,0,1,-2.7,0,-2.3,GO:0060438,trachea development,M101,2,0
1,1,0,-2.8,-2.3,0,GO:0060710,chorio-allantoic fusion,M110,2,0
0,1,1,0,-2.4,-2.1,GO:2000463,positive regulation of excitatory postsynaptic potential,M011,2,0
1,1,0,-4.2,-4.1,0,GO:1901342,regulation of vasculature development,M110,2,0
0,1,1,0,-2.5,-3.1,WP5072,Modulators of TCR signaling and T cell activation,M011,2,0
1,1,0,-2.8,-3.6,0,GO:0042476,odontogenesis,M110,2,0
1,1,0,-6,-2.1,0,GO:1901653,cellular response to peptide,M110,2,0
1,0,1,-2.4,0,-2.4,R-HSA-448424,Interleukin-17 signaling,M101,2,0
1,1,0,-5.2,-5.4,0,GO:0000902,cell morphogenesis,M110,2,0
1,1,0,-3,-3.5,0,GO:0045669,positive regulation of osteoblast differentiation,M110,2,0
1,0,1,-2,0,-3.3,hsa04915,Estrogen signaling pathway,M101,2,0
1,0,1,-5.4,0,-4.5,R-HSA-9658195,Leishmania infection,M101,2,0
1,0,1,-3,0,-5.2,GO:0002262,myeloid cell homeostasis,M101,2,0
1,1,0,-2.8,-4,0,WP4331,Neovascularisation processes,M110,2,0
1,1,0,-3.3,-2.9,0,GO:0002285,lymphocyte activation involved in immune response,M110,2,0
1,0,1,-3.4,0,-2.4,WP2877,Vitamin D receptor pathway,M101,2,0
1,1,0,-2.8,-2.9,0,GO:0098727,maintenance of cell number,M110,2,0
1,1,0,-2.2,-3,0,GO:1903038,negative regulation of leukocyte cell-cell adhesion,M110,2,0
1,0,1,-2.1,0,-2.9,GO:0061515,myeloid cell development,M101,2,0
1,0,1,-2.5,0,-3.2,WP3937,Microglia pathogen phagocytosis pathway,M101,2,0
1,1,0,-3,-2.9,0,GO:0090183,regulation of kidney development,M110,2,0
1,1,0,-2.1,-2.3,0,GO:0007435,salivary gland morphogenesis,M110,2,0
1,1,0,-3.6,-3.7,0,GO:0003143,embryonic heart tube morphogenesis,M110,2,0
1,1,0,-2.5,-3.1,0,GO:0003272,endocardial cushion formation,M110,2,0
0,1,1,0,-3.7,-3.1,GO:0051336,regulation of hydrolase activity,M011,2,0
1,1,0,-2.4,-2.5,0,GO:0032675,regulation of interleukin-6 production,M110,2,0
0,1,1,0,-2.8,-2.1,hsa05152,Tuberculosis,M011,2,0
0,1,1,0,-2.4,-2,GO:0030225,macrophage differentiation,M011,2,0
0,1,1,0,-2.6,-3.6,GO:0032677,regulation of interleukin-8 production,M011,2,0
0,1,1,0,-2.4,-2.1,WP5063,FOXP3 in COVID 19,M011,2,0
0,1,1,0,-2.1,-2.9,GO:0046645,positive regulation of gamma-delta T cell activation,M011,2,0
1,1,0,-2.5,-3,0,GO:1901655,cellular response to ketone,M110,2,0
1,0,1,-6,0,-4.2,GO:0072091,regulation of stem cell proliferation,M101,2,0
1,0,1,-2.1,0,-2.9,GO:0046641,positive regulation of alpha-beta T cell proliferation,M101,2,0
1,1,0,-3.1,-3.2,0,GO:0002702,positive regulation of production of molecular mediator of immune response,M110,2,0
0,1,1,0,-2.7,-5.3,hsa04660,T cell receptor signaling pathway,M011,2,0
1,1,0,-5.8,-2.7,0,GO:0002520,immune system development,M110,2,0
0,1,1,0,-2.3,-3.1,hsa04650,Natural killer cell mediated cytotoxicity,M011,2,0
0,1,1,0,-2.7,-3.1,GO:0032722,positive regulation of chemokine production,M011,2,0
1,1,0,-3.1,-2.1,0,GO:0014706,striated muscle tissue development,M110,2,0
1,0,1,-2.3,0,-6.1,R-HSA-9664417,Leishmania phagocytosis,M101,2,0
0,1,1,0,-6.6,-3.1,GO:0022407,regulation of cell-cell adhesion,M011,2,0
1,1,0,-2.1,-2.9,0,GO:0021502,neural fold elevation formation,M110,2,0
0,1,1,0,-3.1,-2.2,GO:0044092,negative regulation of molecular function,M011,2,0
0,1,1,0,-3.1,-8,WP286,IL 3 signaling pathway,M011,2,0
0,1,1,0,-4.9,-4.2,GO:0050863,regulation of T cell activation,M011,2,0
1,1,0,-2.9,-2.1,0,GO:0007406,negative regulation of neuroblast proliferation,M110,2,0
0,1,1,0,-2.4,-2.3,WP395,IL 4 signaling pathway,M011,2,0
1,1,0,-3.5,-3,0,GO:0048589,developmental growth,M110,2,0
1,0,1,-2.7,0,-4.5,WP2023,Cell differentiation expanded index,M101,2,0
1,1,0,-2.2,-3.1,0,GO:0044706,multi-multicellular organism process,M110,2,0
1,0,1,-3.4,0,-2.8,GO:0021766,hippocampus development,M101,2,0
1,1,0,-2.3,-2.2,0,GO:0034599,cellular response to oxidative stress,M110,2,0
1,1,0,-2.7,-3.3,0,WP4482,Vitamin D in inflammatory diseases,M110,2,0
1,0,1,-2.3,0,-2.9,R-HSA-9012999,RHO GTPase cycle,M101,2,0
1,0,1,-4.7,0,-2.1,WP289,Myometrial relaxation and contraction pathways,M101,2,0
0,1,1,0,-2.4,-2.6,WP4205,MET in type 1 papillary renal cell carcinoma,M011,2,0
1,0,1,-2.2,0,-3.6,GO:0048821,erythrocyte development,M101,2,0
1,1,0,-4.2,-2.4,0,GO:0002293,alpha-beta T cell differentiation involved in immune response,M110,2,0
1,1,0,-5.4,-5.4,0,GO:0060411,cardiac septum morphogenesis,M110,2,0
1,0,1,-4,0,-3.1,R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,M101,2,0
1,1,0,-2.3,-2.8,0,GO:0044703,multi-organism reproductive process,M110,2,0
1,1,0,-4.9,-2,0,hsa04010,MAPK signaling pathway,M110,2,0
0,1,1,0,-2,-2.9,R-HSA-1280218,Adaptive Immune System,M011,2,0
1,1,0,-4.3,-2.6,0,GO:0072189,ureter development,M110,2,0
1,1,0,-2.2,-2.6,0,M23,PID WNT NONCANONICAL PATHWAY,M110,2,0
1,1,0,-2.6,-3.5,0,GO:0060603,mammary gland duct morphogenesis,M110,2,0
1,1,0,-3.1,-3.4,0,WP5381,Smith Magenis and Potocki Lupski syndrome copy number variation,M110,2,0
1,1,0,-2.5,-5.5,0,WP4540,Hippo signaling regulation pathways,M110,2,0
1,0,1,-2,0,-3,hsa05412,Arrhythmogenic right ventricular cardiomyopathy,M101,2,0
1,1,0,-3.6,-2.5,0,GO:0035909,aorta morphogenesis,M110,2,0
1,0,1,-4,0,-6.7,WP3945,TYROBP causal network in microglia,M101,2,0
1,0,1,-2.9,0,-2,R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,M101,2,0
1,1,0,-2.6,-2.7,0,GO:0072009,nephron epithelium development,M110,2,0
0,1,1,0,-4.2,-2.6,hsa05140,Leishmaniasis,M011,2,0
1,0,1,-2.3,0,-3.1,M141,PID PI3KCI PATHWAY,M101,2,0
1,1,0,-4,-4.1,0,GO:0001822,kidney development,M110,2,0
1,0,1,-2.2,0,-3.4,hsa04935,"Growth hormone synthesis, secretion and action",M101,2,0
0,1,1,0,-3.7,-3.5,GO:0021879,forebrain neuron differentiation,M011,2,0
1,1,0,-5.2,-2,0,GO:0009755,hormone-mediated signaling pathway,M110,2,0
1,1,0,-6.5,-5.6,0,GO:0003205,cardiac chamber development,M110,2,0
1,0,1,-2,0,-2.5,R-HSA-388841,Costimulation by the CD28 family,M101,2,0
1,1,0,-7.5,-5.8,0,GO:0001818,negative regulation of cytokine production,M110,2,0
1,1,0,-2.3,-2.5,0,GO:0046620,regulation of organ growth,M110,2,0
0,1,1,0,-3.3,-2,GO:0007159,leukocyte cell-cell adhesion,M011,2,0
1,1,0,-2,-2.6,0,M15,PID LYSOPHOSPHOLIPID PATHWAY,M110,2,0
1,1,0,-2.2,-3.6,0,GO:0040034,"regulation of development, heterochronic",M110,2,0
1,0,1,-5.2,0,-3.1,GO:0060349,bone morphogenesis,M101,2,0
1,1,0,-4.7,-4.5,0,GO:0072001,renal system development,M110,2,0
1,0,1,-2.4,0,-3.1,GO:0021544,subpallium development,M101,2,0
1,1,0,-4.6,-2.5,0,WP5053,Development of ureteric collection system,M110,2,0
1,1,0,-3.4,-2.4,0,GO:0050768,negative regulation of neurogenesis,M110,2,0
1,1,0,-2,-2.6,0,M92,PID ANGIOPOIETIN RECEPTOR PATHWAY,M110,2,0
1,1,0,-2.3,-2.1,0,WP5322,CKAP4 signaling pathway map,M110,2,0
0,1,1,0,-2.4,-3.3,R-HSA-9006335,Signaling by Erythropoietin,M011,2,0
1,1,0,-3,-2.1,0,GO:0010596,negative regulation of endothelial cell migration,M110,2,0
1,1,0,-2.3,-2.4,0,GO:0021532,neural tube patterning,M110,2,0
1,1,0,-4,-2.8,0,WP2355,Corticotropin releasing hormone signaling pathway,M110,2,0
1,1,0,-5.1,-4.1,0,GO:0002064,epithelial cell development,M110,2,0
0,1,1,0,-2.3,-3.1,GO:0050773,regulation of dendrite development,M011,2,0
1,1,0,-3.5,-4.6,0,GO:0120039,plasma membrane bounded cell projection morphogenesis,M110,2,0
1,1,0,-5.1,-4.9,0,GO:0071407,cellular response to organic cyclic compound,M110,2,0
1,0,1,-3,0,-2.4,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,M101,2,0
1,1,0,-3.5,-3,0,GO:0040007,growth,M110,2,0
0,1,1,0,-2.7,-2.2,GO:0032735,positive regulation of interleukin-12 production,M011,2,0
1,1,0,-2.3,-4.7,0,R-HSA-157118,Signaling by NOTCH,M110,2,0
1,1,0,-2.6,-4.6,0,GO:0043433,negative regulation of DNA-binding transcription factor activity,M110,2,0
1,0,1,-3.6,0,-3.2,GO:0022029,telencephalon cell migration,M101,2,0
1,1,0,-3.2,-2.2,0,M166,PID ATF2 PATHWAY,M110,2,0
1,1,0,-4.9,-2.1,0,GO:0001910,regulation of leukocyte mediated cytotoxicity,M110,2,0
0,1,1,0,-2.7,-2.4,GO:0045598,regulation of fat cell differentiation,M011,2,0
1,0,1,-6.2,0,-3.3,R-HSA-198725,Nuclear Events (kinase and transcription factor activation),M101,2,0
1,1,0,-2.9,-5,0,GO:0097485,neuron projection guidance,M110,2,0
1,1,0,-2.4,-2,0,WP3915,Angiopoietin like protein 8 regulatory pathway,M110,2,0
1,1,0,-3.8,-4.3,0,GO:0045765,regulation of angiogenesis,M110,2,0
1,1,0,-3.2,-2.6,0,GO:0051961,negative regulation of nervous system development,M110,2,0
1,1,0,-2.4,-2.2,0,GO:0001101,response to acid chemical,M110,2,0
1,0,1,-2.1,0,-3.3,GO:0050670,regulation of lymphocyte proliferation,M101,2,0
1,0,1,-7.2,0,-4,hsa05161,Hepatitis B,M101,2,0
1,1,0,-3.3,-4.7,0,GO:0048812,neuron projection morphogenesis,M110,2,0
1,1,0,-2.5,-2.9,0,hsa05418,Fluid shear stress and atherosclerosis,M110,2,0
1,0,1,-2.1,0,-2.5,R-HSA-9725370,Signaling by ALK fusions and activated point mutants,M101,2,0
1,1,0,-2.8,-2.7,0,CORUM:5233,TNF-alpha/NF-kappa B signaling complex 5,M110,2,0
1,0,1,-5.1,0,-5,GO:0002761,regulation of myeloid leukocyte differentiation,M101,2,0
1,1,0,-7.8,-7.4,0,GO:0003007,heart morphogenesis,M110,2,0
1,0,1,-2.3,0,-2.2,GO:0035136,forelimb morphogenesis,M101,2,0
1,1,0,-5.9,-5.2,0,GO:0002697,regulation of immune effector process,M110,2,0
1,1,0,-2.9,-2.4,0,GO:0003208,cardiac ventricle morphogenesis,M110,2,0
1,0,1,-4.5,0,-2.2,GO:0060348,bone development,M101,2,0
1,1,0,-3.2,-4.2,0,GO:0014033,neural crest cell differentiation,M110,2,0
0,1,1,0,-2.5,-2.8,WP5224,2q37 copy number variation syndrome,M011,2,0
1,1,0,-2.1,-4.5,0,hsa05224,Breast cancer,M110,2,0
1,1,0,-2.2,-2.6,0,GO:0048534,hematopoietic or lymphoid organ development,M110,2,0
0,1,1,0,-2.4,-2,R-HSA-1257604,PIP3 activates AKT signaling,M011,2,0
0,1,1,0,-2.3,-2.8,GO:0050671,positive regulation of lymphocyte proliferation,M011,2,0
1,0,1,-2.8,0,-2.4,WP4685,Melanoma,M101,2,0
1,0,1,-2.3,0,-2.2,WP2203,Thymic stromal lymphopoietin TSLP signaling pathway,M101,2,0
1,1,0,-3.7,-4.3,0,GO:0001704,formation of primary germ layer,M110,2,0
1,0,1,-2.3,0,-2.6,GO:0002070,epithelial cell maturation,M101,2,0
1,0,1,-3.9,0,-2.5,GO:0007224,smoothened signaling pathway,M101,2,0
1,1,0,-2.9,-2.7,0,GO:0009410,response to xenobiotic stimulus,M110,2,0
0,1,1,0,-2.7,-3.1,WP3863,T cell antigen receptor TCR pathway during Staphylococcus aureus infection,M011,2,0
1,0,1,-4.9,0,-2.5,GO:0060350,endochondral bone morphogenesis,M101,2,0
0,1,1,0,-2.1,-2.3,hsa04668,TNF signaling pathway,M011,2,0
0,1,1,0,-2.5,-2.6,GO:2000107,negative regulation of leukocyte apoptotic process,M011,2,0
1,1,0,-2.4,-2.1,0,GO:1904036,negative regulation of epithelial cell apoptotic process,M110,2,0
1,1,0,-3.2,-3,0,GO:0002700,regulation of production of molecular mediator of immune response,M110,2,0
0,1,1,0,-2.4,-5.8,GO:0030851,granulocyte differentiation,M011,2,0
1,0,1,-4.6,0,-2.9,R-HSA-166520,Signaling by NTRKs,M101,2,0
1,1,0,-3,-2.6,0,R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,M110,2,0
1,1,0,-2.5,-2.2,0,hsa04936,Alcoholic liver disease,M110,2,0
1,1,0,-3.1,-2.6,0,GO:0048708,astrocyte differentiation,M110,2,0
1,0,1,-2.2,0,-3,GO:0030888,regulation of B cell proliferation,M101,2,0
1,1,0,-2.5,-2.5,0,M115,PID REG GR PATHWAY,M110,2,0
1,1,0,-4.3,-2.4,0,GO:0071375,cellular response to peptide hormone stimulus,M110,2,0
1,0,1,-2.3,0,-2.1,GO:0061744,motor behavior,M101,2,0
1,0,1,-2.5,0,-2.3,GO:0021545,cranial nerve development,M101,2,0
0,1,1,0,-2.1,-2.4,GO:0046639,negative regulation of alpha-beta T cell differentiation,M011,2,0
1,1,0,-2.8,-3,0,GO:0072006,nephron development,M110,2,0
1,0,1,-4,0,-3.1,R-HSA-9664433,Leishmania parasite growth and survival,M101,2,0
0,1,1,0,-2,-4,M22,PID GMCSF PATHWAY,M011,2,0
1,1,0,-2.4,-2.1,0,GO:0035265,organ growth,M110,2,0
1,0,1,-5.4,0,-4.5,R-HSA-9824443,Parasitic Infection Pathways,M101,2,0
1,1,0,-2.8,-2.3,0,GO:0042088,T-helper 1 type immune response,M110,2,0
1,1,0,-3,-3.5,0,GO:0003148,outflow tract septum morphogenesis,M110,2,0
1,0,1,-2.3,0,-3.2,GO:0032944,regulation of mononuclear cell proliferation,M101,2,0
1,0,1,-2.1,0,-2.6,WP4928,MAPK pathway in congenital thyroid cancer,M101,2,0
0,1,1,0,-2.5,-7.8,M124,PID CXCR4 PATHWAY,M011,2,0
1,0,1,-4.5,0,-2.6,GO:0032653,regulation of interleukin-10 production,M101,2,0
0,1,1,0,-2.1,-2.1,hsa04611,Platelet activation,M011,2,0
0,1,1,0,-3.9,-2.4,GO:0030101,natural killer cell activation,M011,2,0
1,1,0,-2.1,-3.3,0,WP4949,16p11 2 proximal deletion syndrome,M110,2,0
0,1,1,0,-2.4,-2.1,GO:0045588,positive regulation of gamma-delta T cell differentiation,M011,2,0
1,0,1,-5.8,0,-3.3,R-HSA-187037,Signaling by NTRK1 (TRKA),M101,2,0
1,1,0,-8,-4.8,0,GO:0007507,heart development,M110,2,0
1,1,0,-6.5,-2.5,0,GO:0050777,negative regulation of immune response,M110,2,0
1,0,1,-3.6,0,-2.4,GO:2000648,positive regulation of stem cell proliferation,M101,2,0
1,1,0,-4,-3.2,0,GO:0040008,regulation of growth,M110,2,0
1,1,0,-2.7,-3.6,0,GO:0071277,cellular response to calcium ion,M110,2,0
1,1,0,-6.2,-4.6,0,WP2853,Endoderm differentiation,M110,2,0
1,0,1,-6,0,-2.6,R-HSA-9031628,NGF-stimulated transcription,M101,2,0
1,1,0,-2.2,-2.1,0,GO:0048806,genitalia development,M110,2,0
1,1,0,-2.8,-2.3,0,GO:0035116,embryonic hindlimb morphogenesis,M110,2,0
1,1,0,-2.6,-3.1,0,GO:2000736,regulation of stem cell differentiation,M110,2,0
1,0,1,-2.1,0,-5.9,M8626,SIG BCR SIGNALING PATHWAY,M101,2,0
1,1,0,-4.2,-3.1,0,GO:0014015,positive regulation of gliogenesis,M110,2,0
1,0,1,-2.2,0,-2.1,GO:0051056,regulation of small GTPase mediated signal transduction,M101,2,0
1,1,0,-4.6,-2.8,0,GO:0002067,glandular epithelial cell differentiation,M110,2,0
1,1,0,-4.7,-3.7,0,R-HSA-9758941,Gastrulation,M110,2,0
1,1,0,-3.9,-3.9,0,GO:0072073,kidney epithelium development,M110,2,0
1,0,1,-6,0,-3.3,WP4666,Hepatitis B infection,M101,2,0
0,1,1,0,-5.1,-8.2,GO:0042113,B cell activation,M011,2,0
1,1,0,-2.3,-2.9,0,GO:0031076,embryonic camera-type eye development,M110,2,0
0,1,1,0,-4.4,-4.3,GO:0002757,immune response-activating signaling pathway,M011,2,0
1,0,1,-3.3,0,-2.3,hsa04022,cGMP-PKG signaling pathway,M101,2,0
1,0,1,-2.1,0,-2.8,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,M101,2,0
0,1,1,0,-3.2,-2.3,hsa04072,Phospholipase D signaling pathway,M011,2,0
1,1,0,-4.7,-2,0,GO:0002698,negative regulation of immune effector process,M110,2,0
1,1,0,-4.6,-2.9,0,GO:0009617,response to bacterium,M110,2,0
1,1,0,-2.5,-3.3,0,hsa05032,Morphine addiction,M110,2,0
1,1,0,-3.8,-3.4,0,GO:0001959,regulation of cytokine-mediated signaling pathway,M110,2,0
0,1,1,0,-3.6,-2,GO:0031344,regulation of cell projection organization,M011,2,0
1,1,0,-2.5,-4.5,0,GO:0001837,epithelial to mesenchymal transition,M110,2,0
1,0,1,-2.1,0,-2.6,GO:0021800,cerebral cortex tangential migration,M101,2,0
1,0,1,-3.4,0,-3.2,GO:0021780,glial cell fate specification,M101,2,0
0,1,1,0,-3.2,-3.4,GO:0050866,negative regulation of cell activation,M011,2,0
1,1,0,-4.7,-2.2,0,GO:0030856,regulation of epithelial cell differentiation,M110,2,0
1,0,1,-3.2,0,-3.7,M151,PID AR TF PATHWAY,M101,2,0
1,0,1,-5.1,0,-2.3,WP4216,Chromosomal and microsatellite instability in colorectal cancer,M101,2,0
1,1,0,-4.5,-4.6,0,GO:0048667,cell morphogenesis involved in neuron differentiation,M110,2,0
0,1,1,0,-2.1,-2.9,M268,PID S1P S1P2 PATHWAY,M011,2,0
0,1,1,0,-2.8,-2.4,GO:0008015,blood circulation,M011,2,0
0,1,1,0,-2.3,-4.4,WP585,Interferon type I signaling pathways,M011,2,0
1,1,0,-3.5,-2.8,0,GO:0070099,regulation of chemokine-mediated signaling pathway,M110,2,0
1,1,0,-2.9,-2.3,0,GO:0045088,regulation of innate immune response,M110,2,0
1,1,0,-7.4,-4.4,0,GO:0022612,gland morphogenesis,M110,2,0
1,1,0,-3,-3.9,0,GO:0045622,regulation of T-helper cell differentiation,M110,2,0
1,1,0,-2.8,-2,0,WP4172,PI3K Akt signaling pathway,M110,2,0
1,1,0,-2.2,-3.2,0,WP4541,Hippo Merlin signaling dysregulation,M110,2,0
1,1,0,-2.5,-3.9,0,GO:0048048,embryonic eye morphogenesis,M110,2,0
1,1,0,-13,-7,0,WP2857,Mesodermal commitment pathway,M110,2,0
1,0,1,-2.5,0,-2.7,GO:0002069,columnar/cuboidal epithelial cell maturation,M101,2,0
1,0,1,-4,0,-3,hsa04371,Apelin signaling pathway,M101,2,0
1,1,0,-4.7,-4.1,0,GO:0002703,regulation of leukocyte mediated immunity,M110,2,0
1,1,0,-2.9,-5,0,GO:0007411,axon guidance,M110,2,0
1,1,0,-5.4,-4.8,0,GO:0010594,regulation of endothelial cell migration,M110,2,0
1,0,1,-3,0,-2.2,R-HSA-2871809,FCERI mediated Ca+2 mobilization,M101,2,0
1,1,0,-5.9,-6.3,0,GO:0003206,cardiac chamber morphogenesis,M110,2,0
1,1,0,-2.3,-2.9,0,WP4341,Non genomic actions of 1 25 dihydroxyvitamin D3,M110,2,0
1,1,0,-2.2,-2.3,0,GO:0010595,positive regulation of endothelial cell migration,M110,2,0
1,0,1,-4,0,-3.2,M279,PID RB 1PATHWAY,M101,2,0
1,1,0,-2.1,-2.9,0,GO:0008544,epidermis development,M110,2,0
1,0,1,-2.5,0,-2.4,GO:0099536,synaptic signaling,M101,2,0
1,1,0,-5.4,-3.3,0,GO:0003231,cardiac ventricle development,M110,2,0
1,1,0,-4,-4,0,GO:0072132,mesenchyme morphogenesis,M110,2,0
1,1,0,-2.7,-2.1,0,GO:0032673,regulation of interleukin-4 production,M110,2,0
1,1,0,-3.1,-3.3,0,WP5417,Cell lineage map for neuronal differentiation,M110,2,0
0,1,1,0,-6.4,-2.2,M63,PID AVB3 OPN PATHWAY,M011,2,0
1,1,0,-6.4,-5.4,0,GO:0071396,cellular response to lipid,M110,2,0
0,1,1,0,-2.1,-2.7,GO:0032946,positive regulation of mononuclear cell proliferation,M011,2,0
1,0,1,-3.6,0,-2.5,WP2526,PDGF pathway,M101,2,0
1,0,1,-5.5,0,-4,GO:0050728,negative regulation of inflammatory response,M101,2,0
0,1,1,0,-2,-2,GO:0060441,epithelial tube branching involved in lung morphogenesis,M011,2,0
1,1,0,-2.8,-3,0,WP5094,Orexin receptor pathway,M110,2,0
1,1,0,-6.1,-8.4,0,GO:0060485,mesenchyme development,M110,2,0
1,1,0,-2.3,-2.4,0,R-HSA-76009,Platelet Aggregation (Plug Formation),M110,2,0
1,0,1,-2.3,0,-2.1,GO:0043376,"regulation of CD8-positive, alpha-beta T cell differentiation",M101,2,0
1,1,0,-2.7,-3,0,WP5115,Network map of SARS CoV 2 signaling pathway,M110,2,0
0,1,1,0,-2.7,-3.1,R-HSA-451927,Interleukin-2 family signaling,M011,2,0
1,0,1,-5.3,0,-5.2,GO:0048871,multicellular organismal-level homeostasis,M101,2,0
1,1,0,-4,-2,0,GO:0051145,smooth muscle cell differentiation,M110,2,0
1,1,0,-5,-2.9,0,GO:0002286,T cell activation involved in immune response,M110,2,0
1,0,1,-4,0,-2.8,M223,PID BETA CATENIN NUC PATHWAY,M101,2,0
1,1,0,-4.3,-2,0,WP382,MAPK signaling pathway,M110,2,0
1,1,0,-2.4,-2.1,0,R-HSA-112316,Neuronal System,M110,2,0
0,1,1,0,-3,-3.4,M88,PID CD8 TCR PATHWAY,M011,2,0
1,1,0,-3.1,-3.6,0,GO:1902532,negative regulation of intracellular signal transduction,M110,2,0
1,1,0,-2.5,-2.1,0,GO:0035137,hindlimb morphogenesis,M110,2,0
1,0,1,-3.8,0,-3,GO:0021885,forebrain cell migration,M101,2,0
0,1,1,0,-3.5,-3.8,WP75,Toll like receptor signaling pathway,M011,2,0
1,1,0,-3.1,-3.8,0,GO:0014032,neural crest cell development,M110,2,0
1,1,0,-2.9,-3.4,0,GO:0002720,positive regulation of cytokine production involved in immune response,M110,2,0
1,1,0,-3.4,-3.5,0,GO:0035272,exocrine system development,M110,2,0
1,0,1,-3,0,-2.2,R-HSA-8940973,RUNX2 regulates osteoblast differentiation,M101,2,0
1,0,1,-7.3,0,-2.1,R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,M101,2,0
1,1,0,-4.1,-4.5,0,WP2374,Oncostatin M signaling pathway,M110,2,0
1,1,0,-3.2,-2.1,0,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M110,2,0
0,1,1,0,-2.4,-2.1,GO:0001936,regulation of endothelial cell proliferation,M011,2,0
0,1,1,0,-2.4,-2.7,hsa05142,Chagas disease,M011,2,0
1,1,0,-2.3,-2.2,0,GO:0048538,thymus development,M110,2,0
1,1,0,-2.6,-3.1,0,WP4808,Endochondral ossification with skeletal dysplasias,M110,2,0
1,0,1,-2.1,0,-2.6,GO:0043378,"positive regulation of CD8-positive, alpha-beta T cell differentiation",M101,2,0
0,1,1,0,-3.6,-3.5,GO:0002253,activation of immune response,M011,2,0
1,0,1,-2.4,0,-2.4,GO:0046636,negative regulation of alpha-beta T cell activation,M101,2,0
1,1,0,-3.3,-2.8,0,GO:0030902,hindbrain development,M110,2,0
0,1,1,0,-4.8,-5.3,GO:0050865,regulation of cell activation,M011,2,0
1,1,0,-3.4,-2.8,0,R-HSA-8941326,RUNX2 regulates bone development,M110,2,0
1,1,0,-6.2,-5.2,0,GO:0003279,cardiac septum development,M110,2,0
1,1,0,-2.7,-2.6,0,GO:0001823,mesonephros development,M110,2,0
1,1,0,-4,-7.3,0,GO:0048762,mesenchymal cell differentiation,M110,2,0
1,1,0,-2,-2,0,hsa05213,Endometrial cancer,M110,2,0
1,1,0,-2.7,-2.1,0,WP710,DNA damage response only ATM dependent,M110,2,0
1,1,0,-4.3,-2.8,0,GO:0032680,regulation of tumor necrosis factor production,M110,2,0
1,1,0,-2.3,-2.8,0,GO:0043588,skin development,M110,2,0
0,1,1,0,-2.7,-2.3,GO:0098609,cell-cell adhesion,M011,2,0
0,1,1,0,-5.4,-5.6,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,M011,2,0
1,0,1,-2.3,0,-3.6,M1315,SIG PIP3 SIGNALING IN B LYMPHOCYTES,M101,2,0
1,1,0,-2.4,-2.5,0,GO:0060041,retina development in camera-type eye,M110,2,0
1,1,0,-2.1,-2.4,0,GO:0032479,regulation of type I interferon production,M110,2,0
1,1,0,-3.5,-2.8,0,GO:0097152,mesenchymal cell apoptotic process,M110,2,0
0,1,1,0,-2.5,-2.2,GO:0032642,regulation of chemokine production,M011,2,0
0,1,1,0,-4,-2.2,GO:0001779,natural killer cell differentiation,M011,2,0
1,1,0,-3.8,-2.4,0,M255,PID HIF1 TFPATHWAY,M110,2,0
1,0,1,-2.3,0,-3.1,GO:0032733,positive regulation of interleukin-10 production,M101,2,0
1,1,0,-4.2,-2.4,0,GO:0002287,alpha-beta T cell activation involved in immune response,M110,2,0
1,0,1,-2.5,0,-3.2,GO:0021602,cranial nerve morphogenesis,M101,2,0
1,0,1,-5.9,0,-4,M17200,SA B CELL RECEPTOR COMPLEXES,M101,2,0
0,1,1,0,-2.6,-2.4,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M011,2,0
0,1,1,0,-2.8,-3,hsa04620,Toll-like receptor signaling pathway,M011,2,0
1,1,0,-2.2,-2.6,0,GO:0007565,female pregnancy,M110,2,0
1,1,0,-2.8,-2.3,0,R-HSA-9683610,Maturation of nucleoprotein,M110,2,0
1,1,0,-2.8,-2.7,0,GO:0019827,stem cell population maintenance,M110,2,0
1,1,0,-3.8,-3.5,0,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,M110,2,0
1,1,0,-3.6,-2.4,0,R-HSA-8853884,Transcriptional Regulation by VENTX,M110,2,0
1,1,0,-2.5,-2.8,0,WP5174,Ulcerative colitis signaling,M110,2,0
1,1,0,-2.9,-2.8,0,GO:0072163,mesonephric epithelium development,M110,2,0
1,0,1,-2.9,0,-2,GO:0035306,positive regulation of dephosphorylation,M101,2,0
1,0,1,-3.4,0,-2.8,WP127,IL 5 signaling pathway,M101,2,0
1,0,1,-2.2,0,-2.3,WP2118,Arrhythmogenic right ventricular cardiomyopathy,M101,2,0
1,1,0,-2,-2.2,0,GO:0009612,response to mechanical stimulus,M110,2,0
1,1,0,-2.3,-2.3,0,WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,M110,2,0
1,1,0,-3.9,-4.1,0,GO:0060759,regulation of response to cytokine stimulus,M110,2,0
1,1,0,-3.8,-3.1,0,GO:1901654,response to ketone,M110,2,0
1,0,1,-2.3,0,-3.1,GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,M101,2,0
1,1,0,-2.4,-3.4,0,GO:0030857,negative regulation of epithelial cell differentiation,M110,2,0
1,1,0,-2.5,-2.1,0,GO:0007431,salivary gland development,M110,2,0
1,0,1,-2.1,0,-2.5,R-HSA-9700206,Signaling by ALK in cancer,M101,2,0
1,1,0,-5.6,-2.1,0,hsa04921,Oxytocin signaling pathway,M110,2,0
1,1,0,-4.2,-2.3,0,GO:0032526,response to retinoic acid,M110,2,0
1,1,0,-4.2,-2.3,0,GO:0035904,aorta development,M110,2,0
0,1,1,0,-5,-2.3,GO:0045087,innate immune response,M011,2,0
0,1,1,0,-5.7,-4.2,GO:1903037,regulation of leukocyte cell-cell adhesion,M011,2,0
1,1,0,-2.5,-2.8,0,GO:0032649,regulation of type II interferon production,M110,2,0
1,0,1,-3.8,0,-2.1,WP4255,Non small cell lung cancer,M101,2,0
1,0,1,-4.9,0,-2.3,hsa05210,Colorectal cancer,M101,2,0
1,0,1,-3.6,0,-4.4,R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,M101,2,0
0,1,1,0,-4.4,-4.5,WP5218,Extrafollicular and follicular B cell activation by SARS CoV 2,M011,2,0
1,1,0,-3.2,-2.1,0,GO:0007548,sex differentiation,M110,2,0
1,0,1,-2.3,0,-2.1,GO:2001187,"positive regulation of CD8-positive, alpha-beta T cell activation",M101,2,0
1,1,0,-2.8,-2.1,0,GO:0060627,regulation of vesicle-mediated transport,M110,2,0
1,1,0,-2.8,-2.3,0,R-HSA-9694631,Maturation of nucleoprotein,M110,2,0
1,0,1,-3,0,-2.4,WP1541,Energy metabolism,M101,2,0
1,0,1,-2.8,0,-2.2,hsa05223,Non-small cell lung cancer,M101,2,0
1,0,1,-2.2,0,-2.5,M175,PID ERBB2 ERBB3 PATHWAY,M101,2,0
1,1,0,-2.6,-2.3,0,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,M110,2,0
0,1,1,0,-2.1,-2.9,WP3630,NAD metabolism sirtuins and aging,M011,2,0
1,0,1,-3.8,0,-4.1,GO:0046638,positive regulation of alpha-beta T cell differentiation,M101,2,0
0,1,1,0,-2.1,-4.2,GO:0045648,positive regulation of erythrocyte differentiation,M011,2,0
1,0,1,-2.2,0,-2.3,GO:0032760,positive regulation of tumor necrosis factor production,M101,2,0
0,1,1,0,-3.5,-2.2,GO:0009611,response to wounding,M011,2,0
1,1,0,-2.4,-2.1,0,GO:0051099,positive regulation of binding,M110,2,0
1,1,0,-5.6,-4.2,0,GO:0010632,regulation of epithelial cell migration,M110,2,0
1,1,0,-5.6,-6.3,0,GO:0001709,cell fate determination,M110,2,0
1,1,0,-2.2,-3.6,0,GO:0048505,regulation of timing of cell differentiation,M110,2,0
1,1,0,-2.6,-3.6,0,GO:0045766,positive regulation of angiogenesis,M110,2,0
1,1,0,-2.8,-2.3,0,GO:0043380,regulation of memory T cell differentiation,M110,2,0
1,0,1,-2.2,0,-2.5,R-HSA-389356,CD28 co-stimulation,M101,2,0
1,0,1,-2.2,0,-3.3,hsa05130,Pathogenic Escherichia coli infection,M101,2,0
0,1,1,0,-2.1,-3.2,GO:0042100,B cell proliferation,M011,2,0
1,1,0,-2.5,-2.4,0,GO:0030216,keratinocyte differentiation,M110,2,0
1,1,0,-4.4,-3.4,0,GO:0002699,positive regulation of immune effector process,M110,2,0
1,0,1,-2.1,0,-2.5,hsa04934,Cushing syndrome,M101,2,0
1,1,0,-6.1,-2.8,0,GO:0048545,response to steroid hormone,M110,2,0
0,1,1,0,-3,-2.5,GO:0042116,macrophage activation,M011,2,0
1,0,1,-3.2,0,-3.3,GO:0002763,positive regulation of myeloid leukocyte differentiation,M101,2,0
1,1,0,-3,-3.7,0,hsa04390,Hippo signaling pathway,M110,2,0
1,1,0,-4.1,-3.2,0,GO:0002718,regulation of cytokine production involved in immune response,M110,2,0
1,1,0,-2.5,-2.8,0,GO:0002076,osteoblast development,M110,2,0
1,1,0,-3.8,-3.1,0,WP2858,Ectoderm differentiation,M110,2,0
1,0,1,-3.6,0,-3.6,WP4879,Overlap between signal transduction pathways contributing to LMNA laminopathies,M101,2,0
1,1,0,-2.2,-2.2,0,GO:0071241,cellular response to inorganic substance,M110,2,0
1,0,1,-2,0,-2.3,GO:0043536,positive regulation of blood vessel endothelial cell migration,M101,2,0
1,1,0,-2.1,-2.7,0,GO:0045927,positive regulation of growth,M110,2,0
1,0,1,-2.2,0,-3.8,GO:0050864,regulation of B cell activation,M101,2,0
1,1,0,-2.9,-2.8,0,GO:0072164,mesonephric tubule development,M110,2,0
1,1,0,-2.3,-3.3,0,WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,M110,2,0
1,1,0,-2.9,-2,0,WP4585,Cancer immunotherapy by PD 1 blockade,M110,2,0
1,1,0,-2.3,-2.9,0,hsa04657,IL-17 signaling pathway,M110,2,0
1,0,1,-4.6,0,-2.1,hsa04926,Relaxin signaling pathway,M101,2,0
1,0,1,-3,0,-4,R-HSA-9664323,FCGR3A-mediated IL10 synthesis,M101,2,0
1,1,0,-3,-3.3,0,GO:0048864,stem cell development,M110,2,0
0,1,1,0,-2.2,-2.5,WP3584,MECP2 and associated Rett syndrome,M011,2,0
1,1,0,-2.8,-2.5,0,GO:0010717,regulation of epithelial to mesenchymal transition,M110,2,0
1,1,0,-2.2,-2.1,0,WP5236,Markers of kidney cell lineage,M110,2,0
0,1,1,0,-2.1,-2.4,GO:0032743,positive regulation of interleukin-2 production,M011,2,0
1,1,0,-3.4,-4.5,0,GO:0048858,cell projection morphogenesis,M110,2,0
1,1,0,-2,-2,0,GO:0110110,positive regulation of animal organ morphogenesis,M110,2,0
1,1,0,-4.5,-4.3,0,WP5087,Pleural mesothelioma,M110,2,0
1,0,1,-2.3,0,-3.6,WP4312,Rett syndrome causing genes,M101,2,0
1,0,0,-2.7,0,0,hsa05203,Viral carcinogenesis,M100,1,0
1,0,0,-2.4,0,0,GO:2000179,positive regulation of neural precursor cell proliferation,M100,1,0
1,0,0,-2.1,0,0,R-HSA-112308,Presynaptic depolarization and calcium channel opening,M100,1,0
1,0,0,-2.8,0,0,WP399,Wnt signaling pathway and pluripotency,M100,1,0
1,0,0,-2.1,0,0,GO:0045923,positive regulation of fatty acid metabolic process,M100,1,0
1,0,0,-3.5,0,0,GO:0120161,regulation of cold-induced thermogenesis,M100,1,0
1,0,0,-2.7,0,0,GO:0061008,hepaticobiliary system development,M100,1,0
1,0,0,-2.3,0,0,GO:0070664,negative regulation of leukocyte proliferation,M100,1,0
1,0,0,-2.1,0,0,R-HSA-164378,PKA activation in glucagon signalling,M100,1,0
1,0,0,-2.2,0,0,GO:0007264,small GTPase mediated signal transduction,M100,1,0
0,1,0,0,-3,0,WP2034,Leptin signaling pathway,M010,1,0
1,0,0,-2.2,0,0,GO:0071636,positive regulation of transforming growth factor beta production,M100,1,0
0,1,0,0,-2,0,GO:0001562,response to protozoan,M010,1,0
0,1,0,0,-2.5,0,hsa04145,Phagosome,M010,1,0
0,0,1,0,0,-2.3,GO:0048752,semicircular canal morphogenesis,M001,1,0
0,0,1,0,0,-2.6,GO:0031294,lymphocyte costimulation,M001,1,0
1,0,0,-2.4,0,0,R-HSA-397795,G-protein beta:gamma signalling,M100,1,0
0,1,0,0,-2.8,0,GO:0071353,cellular response to interleukin-4,M010,1,0
0,1,0,0,-2.8,0,GO:0060326,cell chemotaxis,M010,1,0
0,1,0,0,-2.8,0,GO:0050868,negative regulation of T cell activation,M010,1,0
0,1,0,0,-3.2,0,GO:2000977,regulation of forebrain neuron differentiation,M010,1,0
0,1,0,0,-4.8,0,GO:0061564,axon development,M010,1,0
1,0,0,-2.1,0,0,GO:0090009,primitive streak formation,M100,1,0
1,0,0,-2.1,0,0,GO:1904407,positive regulation of nitric oxide metabolic process,M100,1,0
0,0,1,0,0,-2.1,R-HSA-73980,RNA Polymerase III Transcription Termination,M001,1,0
0,1,0,0,-2.8,0,WP5033,Genes associated with the development of rheumatoid arthritis,M010,1,0
1,0,0,-2.5,0,0,GO:0038095,Fc-epsilon receptor signaling pathway,M100,1,0
0,0,1,0,0,-3.2,GO:1904936,interneuron migration,M001,1,0
1,0,0,-2.3,0,0,R-HSA-9694635,Translation of Structural Proteins,M100,1,0
0,1,0,0,-2.1,0,GO:0072075,metanephric mesenchyme development,M010,1,0
1,0,0,-3.2,0,0,GO:0050873,brown fat cell differentiation,M100,1,0
0,1,0,0,-2.1,0,GO:0030595,leukocyte chemotaxis,M010,1,0
0,0,1,0,0,-2.9,R-HSA-8935964,RUNX1 regulates expression of components of tight junctions,M001,1,0
1,0,0,-2.1,0,0,WP3614,Photodynamic therapy induced HIF 1 survival signaling,M100,1,0
0,1,0,0,-2.8,0,hsa05033,Nicotine addiction,M010,1,0
1,0,0,-3.2,0,0,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M100,1,0
1,0,0,-3.9,0,0,hsa04392,Hippo signaling pathway - multiple species,M100,1,0
0,1,0,0,-5.1,0,GO:0032989,cellular anatomical entity morphogenesis,M010,1,0
1,0,0,-2.5,0,0,R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,M100,1,0
0,0,1,0,0,-2.5,GO:0007605,sensory perception of sound,M001,1,0
1,0,0,-2.1,0,0,WP4239,Epithelial to mesenchymal transition in colorectal cancer,M100,1,0
1,0,0,-2.1,0,0,GO:0021527,spinal cord association neuron differentiation,M100,1,0
1,0,0,-3.5,0,0,GO:0009991,response to extracellular stimulus,M100,1,0
1,0,0,-2.4,0,0,WP4877,Host pathogen interaction of human coronaviruses MAPK signaling,M100,1,0
1,0,0,-2.9,0,0,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,M100,1,0
1,0,0,-3.2,0,0,GO:0014743,regulation of muscle hypertrophy,M100,1,0
0,0,1,0,0,-2,GO:0008589,regulation of smoothened signaling pathway,M001,1,0
1,0,0,-2.2,0,0,GO:0006953,acute-phase response,M100,1,0
0,1,0,0,-2.5,0,GO:0043300,regulation of leukocyte degranulation,M010,1,0
0,1,0,0,-2.4,0,GO:1905278,positive regulation of epithelial tube formation,M010,1,0
1,0,0,-2.1,0,0,CORUM:3045,hs4 enhancer complex (faster migrating complex),M100,1,0
0,0,1,0,0,-3.5,R-HSA-164944,Nef and signal transduction,M001,1,0
0,1,0,0,-2.2,0,GO:0043549,regulation of kinase activity,M010,1,0
1,0,0,-2.2,0,0,GO:0032945,negative regulation of mononuclear cell proliferation,M100,1,0
0,1,0,0,-2.5,0,hsa04924,Renin secretion,M010,1,0
1,0,0,-3.8,0,0,WP4263,Pancreatic adenocarcinoma pathway,M100,1,0
1,0,0,-2.8,0,0,GO:0014009,glial cell proliferation,M100,1,0
1,0,0,-2.2,0,0,GO:0048592,eye morphogenesis,M100,1,0
0,1,0,0,-2.2,0,WP2328,Allograft rejection,M010,1,0
0,1,0,0,-2.3,0,GO:0060685,regulation of prostatic bud formation,M010,1,0
1,0,0,-2.1,0,0,GO:0030836,positive regulation of actin filament depolymerization,M100,1,0
0,1,0,0,-2.8,0,GO:0002399,MHC class II protein complex assembly,M010,1,0
1,0,0,-2.1,0,0,CORUM:5735,TGF-beta receptor-SMAD3 complex,M100,1,0
1,0,0,-2.1,0,0,GO:0032688,negative regulation of interferon-beta production,M100,1,0
1,0,0,-2.6,0,0,GO:0032732,positive regulation of interleukin-1 production,M100,1,0
1,0,0,-2.1,0,0,GO:0002825,regulation of T-helper 1 type immune response,M100,1,0
1,0,0,-3.6,0,0,GO:0032652,regulation of interleukin-1 production,M100,1,0
1,0,0,-2.4,0,0,R-HSA-9634597,GPER1 signaling,M100,1,0
1,0,0,-2.6,0,0,GO:0003176,aortic valve development,M100,1,0
0,1,0,0,-2.2,0,GO:0048660,regulation of smooth muscle cell proliferation,M010,1,0
0,1,0,0,-2,0,GO:0060390,regulation of SMAD protein signal transduction,M010,1,0
0,1,0,0,-2.4,0,R-HSA-199991,Membrane Trafficking,M010,1,0
1,0,0,-3.5,0,0,hsa05226,Gastric cancer,M100,1,0
1,0,0,-2.8,0,0,GO:0045981,positive regulation of nucleotide metabolic process,M100,1,0
1,0,0,-2.2,0,0,GO:0002483,antigen processing and presentation of endogenous peptide antigen,M100,1,0
0,1,0,0,-2.4,0,GO:0010863,positive regulation of phospholipase C activity,M010,1,0
0,0,1,0,0,-5,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,M001,1,0
1,0,0,-2.7,0,0,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,M100,1,0
0,1,0,0,-3,0,GO:0040017,positive regulation of locomotion,M010,1,0
0,0,1,0,0,-2.4,GO:0045746,negative regulation of Notch signaling pathway,M001,1,0
1,0,0,-2.1,0,0,GO:0090189,regulation of branching involved in ureteric bud morphogenesis,M100,1,0
1,0,0,-2.1,0,0,GO:0060563,neuroepithelial cell differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:0022028,tangential migration from the subventricular zone to the olfactory bulb,M100,1,0
1,0,0,-3.2,0,0,M229,PID P38 ALPHA BETA DOWNSTREAM PATHWAY,M100,1,0
0,0,1,0,0,-2,R-HSA-2029485,Role of phospholipids in phagocytosis,M001,1,0
0,0,1,0,0,-2.1,GO:0046629,gamma-delta T cell activation,M001,1,0
0,0,1,0,0,-2.1,R-HSA-4420097,VEGFA-VEGFR2 Pathway,M001,1,0
1,0,0,-2.2,0,0,GO:0060571,morphogenesis of an epithelial fold,M100,1,0
1,0,0,-4.6,0,0,GO:0071634,regulation of transforming growth factor beta production,M100,1,0
1,0,0,-2.1,0,0,GO:0071474,cellular hyperosmotic response,M100,1,0
0,1,0,0,-2.2,0,GO:2000401,regulation of lymphocyte migration,M010,1,0
0,1,0,0,-2.4,0,GO:1904035,regulation of epithelial cell apoptotic process,M010,1,0
1,0,0,-4,0,0,hsa04350,TGF-beta signaling pathway,M100,1,0
0,0,1,0,0,-4.2,R-HSA-912631,Regulation of signaling by CBL,M001,1,0
1,0,0,-2.3,0,0,WP5144,NRP1 triggered signaling pathways in pancreatic cancer,M100,1,0
0,1,0,0,-3.2,0,R-HSA-8939902,Regulation of RUNX2 expression and activity,M010,1,0
1,0,0,-2.2,0,0,GO:1901985,positive regulation of protein acetylation,M100,1,0
1,0,0,-2,0,0,R-HSA-400206,Regulation of lipid metabolism by PPARalpha,M100,1,0
1,0,0,-3.8,0,0,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",M100,1,0
0,0,1,0,0,-3.2,GO:1902106,negative regulation of leukocyte differentiation,M001,1,0
0,1,0,0,-2.9,0,R-HSA-9673324,WNT5:FZD7-mediated leishmania damping,M010,1,0
0,1,0,0,-3.7,0,GO:0046903,secretion,M010,1,0
0,1,0,0,-3,0,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,M010,1,0
1,0,0,-2.1,0,0,GO:0021853,cerebral cortex GABAergic interneuron migration,M100,1,0
0,0,1,0,0,-3.9,R-HSA-2029481,FCGR activation,M001,1,0
1,0,0,-3,0,0,GO:0061458,reproductive system development,M100,1,0
0,0,1,0,0,-2.9,GO:0032757,positive regulation of interleukin-8 production,M001,1,0
0,1,0,0,-3.4,0,GO:0040011,locomotion,M010,1,0
0,1,0,0,-2.4,0,GO:0002831,regulation of response to biotic stimulus,M010,1,0
1,0,0,-2.1,0,0,GO:0110022,regulation of cardiac muscle myoblast proliferation,M100,1,0
1,0,0,-3.2,0,0,R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,M100,1,0
1,0,0,-5.3,0,0,GO:0001666,response to hypoxia,M100,1,0
1,0,0,-2.4,0,0,GO:0019080,viral gene expression,M100,1,0
1,0,0,-2.8,0,0,WP2018,RANKL RANK signaling pathway,M100,1,0
1,0,0,-2.8,0,0,M28,PID IL4 2PATHWAY,M100,1,0
0,0,1,0,0,-2.9,GO:0043249,erythrocyte maturation,M001,1,0
0,1,0,0,-2.1,0,GO:0090322,regulation of superoxide metabolic process,M010,1,0
0,1,0,0,-3.8,0,GO:0032763,regulation of mast cell cytokine production,M010,1,0
1,0,0,-4.1,0,0,WP4241,Type 2 papillary renal cell carcinoma,M100,1,0
0,1,0,0,-2.9,0,GO:0071698,olfactory placode development,M010,1,0
1,0,0,-2.2,0,0,GO:0097009,energy homeostasis,M100,1,0
0,0,1,0,0,-2,GO:0050807,regulation of synapse organization,M001,1,0
0,1,0,0,-2.4,0,GO:0032350,regulation of hormone metabolic process,M010,1,0
0,1,0,0,-2.8,0,GO:0031016,pancreas development,M010,1,0
0,1,0,0,-2.2,0,GO:0001934,positive regulation of protein phosphorylation,M010,1,0
0,1,0,0,-2.5,0,hsa00230,Purine metabolism,M010,1,0
0,1,0,0,-2.4,0,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,M010,1,0
1,0,0,-2.6,0,0,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,M100,1,0
1,0,0,-2.1,0,0,GO:0007028,cytoplasm organization,M100,1,0
1,0,0,-2.2,0,0,WP516,Hypertrophy model,M100,1,0
0,1,0,0,-2.3,0,GO:0048541,Peyer's patch development,M010,1,0
0,0,1,0,0,-4.4,WP4304,Oligodendrocyte specification and differentiation leading to myelin components for CNS,M001,1,0
1,0,0,-2.7,0,0,WP53,ID signaling pathway,M100,1,0
0,1,0,0,-2.7,0,R-HSA-354192,Integrin signaling,M010,1,0
1,0,0,-4.2,0,0,WP4535,Envelope proteins and their potential roles in EDMD physiopathology,M100,1,0
1,0,0,-3.6,0,0,GO:0002708,positive regulation of lymphocyte mediated immunity,M100,1,0
1,0,0,-3,0,0,WP5180,DYRK1A involvement regarding cell proliferation in brain development,M100,1,0
1,0,0,-3.8,0,0,GO:0042093,T-helper cell differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:0010458,exit from mitosis,M100,1,0
1,0,0,-3.3,0,0,R-HSA-166166,MyD88-independent TLR4 cascade,M100,1,0
1,0,0,-2.8,0,0,GO:1900016,negative regulation of cytokine production involved in inflammatory response,M100,1,0
1,0,0,-4.1,0,0,M33,PID GLYPICAN 1PATHWAY,M100,1,0
0,1,0,0,-2.2,0,GO:0070232,regulation of T cell apoptotic process,M010,1,0
1,0,0,-3.2,0,0,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,M100,1,0
1,0,0,-2.4,0,0,GO:0009855,determination of bilateral symmetry,M100,1,0
1,0,0,-2,0,0,GO:0002931,response to ischemia,M100,1,0
1,0,0,-2.9,0,0,M145,PID P53 DOWNSTREAM PATHWAY,M100,1,0
1,0,0,-2.5,0,0,R-HSA-163685,Integration of energy metabolism,M100,1,0
0,0,1,0,0,-2.5,GO:0071425,hematopoietic stem cell proliferation,M001,1,0
0,1,0,0,-2.4,0,GO:0070243,regulation of thymocyte apoptotic process,M010,1,0
0,0,1,0,0,-2,GO:0050954,sensory perception of mechanical stimulus,M001,1,0
1,0,0,-2,0,0,GO:0017157,regulation of exocytosis,M100,1,0
0,0,1,0,0,-2.1,GO:0006469,negative regulation of protein kinase activity,M001,1,0
1,0,0,-2.2,0,0,WP481,Insulin signaling,M100,1,0
0,1,0,0,-2.3,0,GO:0033674,positive regulation of kinase activity,M010,1,0
0,1,0,0,-3.1,0,R-HSA-5683057,MAPK family signaling cascades,M010,1,0
1,0,0,-2.5,0,0,R-HSA-3232118,SUMOylation of transcription factors,M100,1,0
1,0,0,-3,0,0,WP2911,miRNA targets in ECM and membrane receptors,M100,1,0
0,1,0,0,-2.1,0,GO:2000772,regulation of cellular senescence,M010,1,0
0,1,0,0,-2.6,0,GO:0070233,negative regulation of T cell apoptotic process,M010,1,0
1,0,0,-2.3,0,0,GO:0033151,V(D)J recombination,M100,1,0
1,0,0,-2.7,0,0,GO:0010718,positive regulation of epithelial to mesenchymal transition,M100,1,0
1,0,0,-2.6,0,0,GO:1903580,positive regulation of ATP metabolic process,M100,1,0
0,1,0,0,-3.8,0,GO:0048341,paraxial mesoderm formation,M010,1,0
0,1,0,0,-2.3,0,GO:0060214,endocardium formation,M010,1,0
1,0,0,-2.1,0,0,R-HSA-1912408,Pre-NOTCH Transcription and Translation,M100,1,0
0,0,1,0,0,-2.8,GO:0043299,leukocyte degranulation,M001,1,0
1,0,0,-2.1,0,0,GO:0043435,response to corticotropin-releasing hormone,M100,1,0
0,1,0,0,-2.3,0,GO:0072107,positive regulation of ureteric bud formation,M010,1,0
0,0,1,0,0,-2.6,GO:0050764,regulation of phagocytosis,M001,1,0
1,0,0,-2.8,0,0,WP4321,Thermogenesis,M100,1,0
1,0,0,-3.4,0,0,GO:0045824,negative regulation of innate immune response,M100,1,0
0,0,1,0,0,-2.8,hsa04664,Fc epsilon RI signaling pathway,M001,1,0
1,0,0,-2.8,0,0,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,M100,1,0
0,0,1,0,0,-2.6,GO:0072525,pyridine-containing compound biosynthetic process,M001,1,0
1,0,0,-2.4,0,0,R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,M100,1,0
0,1,0,0,-2,0,WP428,Wnt signaling,M010,1,0
0,0,1,0,0,-2.3,GO:0060397,growth hormone receptor signaling pathway via JAK-STAT,M001,1,0
1,0,0,-2.8,0,0,GO:0120162,positive regulation of cold-induced thermogenesis,M100,1,0
0,1,0,0,-2.9,0,GO:0033262,regulation of nuclear cell cycle DNA replication,M010,1,0
0,0,1,0,0,-2.6,R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),M001,1,0
0,1,0,0,-2.2,0,R-HSA-8878171,Transcriptional regulation by RUNX1,M010,1,0
1,0,0,-2.1,0,0,GO:0051047,positive regulation of secretion,M100,1,0
0,0,1,0,0,-2.4,R-HSA-9013149,RAC1 GTPase cycle,M001,1,0
0,1,0,0,-3.8,0,GO:0090287,regulation of cellular response to growth factor stimulus,M010,1,0
0,1,0,0,-2.4,0,GO:0060079,excitatory postsynaptic potential,M010,1,0
0,1,0,0,-2.8,0,GO:0034391,regulation of smooth muscle cell apoptotic process,M010,1,0
0,1,0,0,-2.4,0,R-HSA-9818749,Regulation of NFE2L2 gene expression,M010,1,0
1,0,0,-4.2,0,0,R-HSA-2424491,DAP12 signaling,M100,1,0
0,0,1,0,0,-2.5,GO:0046643,regulation of gamma-delta T cell activation,M001,1,0
0,1,0,0,-2.8,0,GO:0021952,central nervous system projection neuron axonogenesis,M010,1,0
0,0,1,0,0,-2.6,GO:0050775,positive regulation of dendrite morphogenesis,M001,1,0
1,0,0,-2.8,0,0,GO:0002832,negative regulation of response to biotic stimulus,M100,1,0
1,0,0,-2.5,0,0,R-HSA-111933,Calmodulin induced events,M100,1,0
1,0,0,-3.7,0,0,R-HSA-4090294,SUMOylation of intracellular receptors,M100,1,0
1,0,0,-2.5,0,0,GO:0003310,pancreatic A cell differentiation,M100,1,0
0,1,0,0,-5.8,0,GO:0007162,negative regulation of cell adhesion,M010,1,0
1,0,0,-2.1,0,0,GO:0010891,negative regulation of sequestering of triglyceride,M100,1,0
0,1,0,0,-2.9,0,GO:0060374,mast cell differentiation,M010,1,0
1,0,0,-2.3,0,0,WP1471,Target of rapamycin signaling,M100,1,0
1,0,0,-2,0,0,WP179,Cell cycle,M100,1,0
1,0,0,-2.4,0,0,GO:0009799,specification of symmetry,M100,1,0
1,0,0,-2.1,0,0,R-HSA-76002,"Platelet activation, signaling and aggregation",M100,1,0
0,0,1,0,0,-2.4,GO:0036075,replacement ossification,M001,1,0
1,0,0,-2.5,0,0,GO:0061035,regulation of cartilage development,M100,1,0
0,1,0,0,-2.6,0,GO:0002396,MHC protein complex assembly,M010,1,0
0,1,0,0,-2.4,0,GO:0002886,regulation of myeloid leukocyte mediated immunity,M010,1,0
1,0,0,-2.3,0,0,GO:0002052,positive regulation of neuroblast proliferation,M100,1,0
1,0,0,-2.8,0,0,WP3299,let 7 inhibition of ES cell reprogramming,M100,1,0
0,1,0,0,-2.1,0,GO:0002730,regulation of dendritic cell cytokine production,M010,1,0
0,1,0,0,-3.3,0,R-HSA-6798695,Neutrophil degranulation,M010,1,0
0,1,0,0,-3.6,0,GO:0071696,ectodermal placode development,M010,1,0
1,0,0,-4.3,0,0,GO:0002705,positive regulation of leukocyte mediated immunity,M100,1,0
1,0,0,-4,0,0,GO:0003417,growth plate cartilage development,M100,1,0
1,0,0,-2.8,0,0,GO:0035910,ascending aorta morphogenesis,M100,1,0
0,1,0,0,-2.2,0,GO:0010817,regulation of hormone levels,M010,1,0
1,0,0,-2.5,0,0,R-HSA-397014,Muscle contraction,M100,1,0
1,0,0,-2.8,0,0,GO:0021546,rhombomere development,M100,1,0
0,1,0,0,-2.2,0,R-HSA-372790,Signaling by GPCR,M010,1,0
1,0,0,-2.7,0,0,GO:0030500,regulation of bone mineralization,M100,1,0
1,0,0,-2.1,0,0,R-HSA-3656532,TGFBR1 KD Mutants in Cancer,M100,1,0
1,0,0,-2.1,0,0,GO:0060164,regulation of timing of neuron differentiation,M100,1,0
0,0,1,0,0,-2,GO:0034103,regulation of tissue remodeling,M001,1,0
1,0,0,-2.1,0,0,CORUM:3030,TGF-beta receptor II-TGF-beta receptor I-TGF-beta1 complex,M100,1,0
1,0,0,-2.1,0,0,GO:0046015,regulation of transcription by glucose,M100,1,0
0,1,0,0,-2.8,0,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,M010,1,0
0,1,0,0,-2.4,0,GO:0048846,axon extension involved in axon guidance,M010,1,0
0,1,0,0,-2.4,0,GO:1905276,regulation of epithelial tube formation,M010,1,0
0,1,0,0,-2.4,0,GO:0007350,blastoderm segmentation,M010,1,0
0,1,0,0,-2.5,0,GO:0090497,mesenchymal cell migration,M010,1,0
1,0,0,-2.3,0,0,hsa04912,GnRH signaling pathway,M100,1,0
0,1,0,0,-2.8,0,GO:0071219,cellular response to molecule of bacterial origin,M010,1,0
1,0,0,-2.4,0,0,GO:0043392,negative regulation of DNA binding,M100,1,0
0,1,0,0,-3.5,0,GO:1990868,response to chemokine,M010,1,0
1,0,0,-2.1,0,0,GO:1902462,positive regulation of mesenchymal stem cell proliferation,M100,1,0
1,0,0,-3.6,0,0,GO:0048511,rhythmic process,M100,1,0
0,1,0,0,-2.3,0,R-HSA-372708,p130Cas linkage to MAPK signaling for integrins,M010,1,0
1,0,0,-2.8,0,0,WP3672,lncRNA mediated mechanisms of therapeutic resistance,M100,1,0
1,0,0,-3.4,0,0,WP4746,Thyroid hormones production and peripheral downstream signaling effects,M100,1,0
1,0,0,-2.7,0,0,M285,PID HNF3A PATHWAY,M100,1,0
0,0,1,0,0,-2.3,GO:0062009,secondary palate development,M001,1,0
0,1,0,0,-2.7,0,GO:0045860,positive regulation of protein kinase activity,M010,1,0
1,0,0,-3.4,0,0,GO:0009299,mRNA transcription,M100,1,0
1,0,0,-2.7,0,0,R-HSA-9683701,Translation of Structural Proteins,M100,1,0
1,0,0,-2.5,0,0,GO:0030501,positive regulation of bone mineralization,M100,1,0
1,0,0,-2.2,0,0,GO:1903306,negative regulation of regulated secretory pathway,M100,1,0
1,0,0,-2.1,0,0,GO:0015014,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process",M100,1,0
0,1,0,0,-2.8,0,GO:0010518,positive regulation of phospholipase activity,M010,1,0
1,0,0,-3.1,0,0,WP2855,Dopaminergic neurogenesis,M100,1,0
1,0,0,-2.3,0,0,GO:0008038,neuron recognition,M100,1,0
0,0,1,0,0,-2,GO:0051170,import into nucleus,M001,1,0
1,0,0,-4.8,0,0,R-HSA-9018519,Estrogen-dependent gene expression,M100,1,0
1,0,0,-2.8,0,0,GO:1900544,positive regulation of purine nucleotide metabolic process,M100,1,0
0,0,1,0,0,-2.1,GO:0048935,peripheral nervous system neuron development,M001,1,0
0,1,0,0,-3.8,0,GO:1905331,negative regulation of morphogenesis of an epithelium,M010,1,0
1,0,0,-2.1,0,0,WP4534,Mechanoregulation and pathology of YAP TAZ via Hippo and non Hippo mechanisms,M100,1,0
0,1,0,0,-2.9,0,GO:0002318,myeloid progenitor cell differentiation,M010,1,0
1,0,0,-2.1,0,0,R-HSA-3304356,SMAD2/3 Phosphorylation Motif Mutants in Cancer,M100,1,0
0,1,0,0,-2.9,0,GO:0006105,succinate metabolic process,M010,1,0
1,0,0,-2.2,0,0,GO:0030282,bone mineralization,M100,1,0
0,0,1,0,0,-2.6,GO:0045060,negative thymic T cell selection,M001,1,0
1,0,0,-2.1,0,0,WP5036,Angiotensin II receptor type 1 pathway,M100,1,0
0,1,0,0,-2.3,0,R-HSA-438066,"Unblocking of NMDA receptors, glutamate binding and activation",M010,1,0
1,0,0,-2.1,0,0,GO:2000774,positive regulation of cellular senescence,M100,1,0
1,0,0,-2.3,0,0,GO:0002063,chondrocyte development,M100,1,0
1,0,0,-2,0,0,GO:0052548,regulation of endopeptidase activity,M100,1,0
1,0,0,-6,0,0,GO:1902894,negative regulation of miRNA transcription,M100,1,0
0,1,0,0,-2.1,0,GO:2000352,negative regulation of endothelial cell apoptotic process,M010,1,0
0,1,0,0,-2.4,0,GO:0043304,regulation of mast cell degranulation,M010,1,0
1,0,0,-2.1,0,0,GO:0070633,transepithelial transport,M100,1,0
1,0,0,-2.8,0,0,GO:0060412,ventricular septum morphogenesis,M100,1,0
0,1,0,0,-2.8,0,WP3927,BMP signaling in eyelid development,M010,1,0
0,0,1,0,0,-2.7,GO:0045061,thymic T cell selection,M001,1,0
0,1,0,0,-2.5,0,GO:0051347,positive regulation of transferase activity,M010,1,0
1,0,0,-2.1,0,0,GO:0032411,positive regulation of transporter activity,M100,1,0
0,0,1,0,0,-2.5,R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,M001,1,0
1,0,0,-3.1,0,0,GO:0062013,positive regulation of small molecule metabolic process,M100,1,0
1,0,0,-2.7,0,0,GO:0036294,cellular response to decreased oxygen levels,M100,1,0
1,0,0,-2.1,0,0,GO:0021903,rostrocaudal neural tube patterning,M100,1,0
1,0,0,-3.2,0,0,hsa05211,Renal cell carcinoma,M100,1,0
0,1,0,0,-2.8,0,hsa05131,Shigellosis,M010,1,0
1,0,0,-2.5,0,0,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,M100,1,0
0,0,1,0,0,-2.8,GO:0021801,cerebral cortex radial glia-guided migration,M001,1,0
0,1,0,0,-2.1,0,GO:0034614,cellular response to reactive oxygen species,M010,1,0
1,0,0,-3.2,0,0,R-HSA-5619507,Activation of HOX genes during differentiation,M100,1,0
1,0,0,-2.8,0,0,GO:0010614,negative regulation of cardiac muscle hypertrophy,M100,1,0
1,0,0,-2.7,0,0,hsa04971,Gastric acid secretion,M100,1,0
1,0,0,-3.8,0,0,GO:0032651,regulation of interleukin-1 beta production,M100,1,0
1,0,0,-4.3,0,0,GO:0001525,angiogenesis,M100,1,0
1,0,0,-2.1,0,0,WP4269,Ethanol metabolism production of ROS by CYP2E1,M100,1,0
1,0,0,-2.1,0,0,M81,PID CDC42 PATHWAY,M100,1,0
1,0,0,-3.4,0,0,GO:0035264,multicellular organism growth,M100,1,0
1,0,0,-3.3,0,0,R-HSA-5362517,Signaling by Retinoic Acid,M100,1,0
1,0,0,-2.1,0,0,R-HSA-1592230,Mitochondrial biogenesis,M100,1,0
0,1,0,0,-2.3,0,GO:0007215,glutamate receptor signaling pathway,M010,1,0
0,1,0,0,-2.4,0,GO:0043254,regulation of protein-containing complex assembly,M010,1,0
0,0,1,0,0,-2.3,R-HSA-8951936,RUNX3 regulates p14-ARF,M001,1,0
0,0,1,0,0,-2.3,GO:0098976,excitatory chemical synaptic transmission,M001,1,0
0,1,0,0,-4.1,0,GO:0032940,secretion by cell,M010,1,0
1,0,0,-3.2,0,0,GO:0002707,negative regulation of lymphocyte mediated immunity,M100,1,0
1,0,0,-3.4,0,0,WP2880,Glucocorticoid receptor pathway,M100,1,0
1,0,0,-4,0,0,GO:0003170,heart valve development,M100,1,0
0,1,0,0,-2.4,0,GO:0031345,negative regulation of cell projection organization,M010,1,0
1,0,0,-2.5,0,0,GO:0009914,hormone transport,M100,1,0
1,0,0,-2.8,0,0,GO:0007413,axonal fasciculation,M100,1,0
0,1,0,0,-3.6,0,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,M010,1,0
0,1,0,0,-2,0,GO:0006022,aminoglycan metabolic process,M010,1,0
0,0,1,0,0,-2.5,WP3591,Sleep regulation,M001,1,0
0,1,0,0,-2.2,0,hsa01522,Endocrine resistance,M010,1,0
1,0,0,-2.8,0,0,GO:0071456,cellular response to hypoxia,M100,1,0
1,0,0,-2.1,0,0,GO:0097264,self proteolysis,M100,1,0
1,0,0,-2.1,0,0,GO:1901983,regulation of protein acetylation,M100,1,0
0,1,0,0,-3,0,GO:0030031,cell projection assembly,M010,1,0
0,1,0,0,-3.7,0,GO:0120035,regulation of plasma membrane bounded cell projection organization,M010,1,0
0,1,0,0,-2.3,0,R-HSA-9020558,Interleukin-2 signaling,M010,1,0
0,0,1,0,0,-2.3,GO:0007229,integrin-mediated signaling pathway,M001,1,0
0,0,1,0,0,-2.1,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,M001,1,0
1,0,0,-2.2,0,0,GO:0007622,rhythmic behavior,M100,1,0
0,0,1,0,0,-3.3,GO:0045600,positive regulation of fat cell differentiation,M001,1,0
1,0,0,-2.6,0,0,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,M100,1,0
1,0,0,-3.2,0,0,WP3932,Focal adhesion PI3K Akt mTOR signaling pathway,M100,1,0
1,0,0,-2.7,0,0,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,M100,1,0
0,1,0,0,-2.4,0,GO:0070229,negative regulation of lymphocyte apoptotic process,M010,1,0
0,1,0,0,-3.8,0,GO:0022408,negative regulation of cell-cell adhesion,M010,1,0
0,1,0,0,-2.8,0,WP4481,Resistin as a regulator of inflammation,M010,1,0
0,1,0,0,-2,0,GO:0044344,cellular response to fibroblast growth factor stimulus,M010,1,0
1,0,0,-3,0,0,WP4658,Small cell lung cancer,M100,1,0
1,0,0,-2.5,0,0,R-HSA-450294,MAP kinase activation,M100,1,0
0,1,0,0,-2.6,0,GO:0050886,endocrine process,M010,1,0
1,0,0,-2.1,0,0,GO:0014887,cardiac muscle adaptation,M100,1,0
0,1,0,0,-2.1,0,GO:0060193,positive regulation of lipase activity,M010,1,0
1,0,0,-3.2,0,0,WP3611,Photodynamic therapy induced AP 1 survival signaling,M100,1,0
1,0,0,-2.1,0,0,R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,M100,1,0
0,1,0,0,-3.5,0,WP3678,Amplification and expansion of oncogenic pathways as metastatic traits,M010,1,0
0,1,0,0,-3.7,0,M165,PID SYNDECAN 4 PATHWAY,M010,1,0
0,1,0,0,-3.1,0,hsa04625,C-type lectin receptor signaling pathway,M010,1,0
0,0,1,0,0,-2,GO:1902074,response to salt,M001,1,0
0,1,0,0,-2.1,0,GO:0021889,olfactory bulb interneuron differentiation,M010,1,0
1,0,0,-2.1,0,0,GO:0055059,asymmetric neuroblast division,M100,1,0
1,0,0,-3,0,0,WP3680,Physico chemical features and toxicity associated pathways,M100,1,0
1,0,0,-2.3,0,0,GO:0060972,left/right pattern formation,M100,1,0
1,0,0,-2.3,0,0,GO:0070371,ERK1 and ERK2 cascade,M100,1,0
0,1,0,0,-2.2,0,hsa05206,MicroRNAs in cancer,M010,1,0
1,0,0,-2.7,0,0,GO:0031214,biomineral tissue development,M100,1,0
0,1,0,0,-2,0,GO:0090335,regulation of brown fat cell differentiation,M010,1,0
0,1,0,0,-2.4,0,GO:0030866,cortical actin cytoskeleton organization,M010,1,0
1,0,0,-3.4,0,0,WP5216,Warburg effect modulated by deubiquitinating enzymes and their substrates,M100,1,0
0,1,0,0,-2.2,0,R-HSA-202427,Phosphorylation of CD3 and TCR zeta chains,M010,1,0
1,0,0,-2.8,0,0,WP2795,Cardiac hypertrophic response,M100,1,0
0,1,0,0,-2.1,0,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),M010,1,0
1,0,0,-2,0,0,GO:0001678,intracellular glucose homeostasis,M100,1,0
1,0,0,-2.3,0,0,GO:1901201,regulation of extracellular matrix assembly,M100,1,0
1,0,0,-2.3,0,0,WP1991,SRF and miRs in smooth muscle differentiation and proliferation,M100,1,0
0,1,0,0,-2.7,0,R-HSA-6811438,Intra-Golgi traffic,M010,1,0
1,0,0,-2.6,0,0,GO:0071453,cellular response to oxygen levels,M100,1,0
0,1,0,0,-2.4,0,GO:0032695,negative regulation of interleukin-12 production,M010,1,0
0,0,1,0,0,-2,GO:0050803,regulation of synapse structure or activity,M001,1,0
1,0,0,-3.2,0,0,hsa05220,Chronic myeloid leukemia,M100,1,0
1,0,0,-2.1,0,0,GO:0009449,gamma-aminobutyric acid biosynthetic process,M100,1,0
1,0,0,-2.8,0,0,R-HSA-210455,Astrocytic Glutamate-Glutamine Uptake And Metabolism,M100,1,0
1,0,0,-2.4,0,0,GO:0034198,cellular response to amino acid starvation,M100,1,0
1,0,0,-4.4,0,0,GO:0031342,negative regulation of cell killing,M100,1,0
0,0,1,0,0,-2.4,hsa04024,cAMP signaling pathway,M001,1,0
0,0,1,0,0,-2.3,GO:0002071,glandular epithelial cell maturation,M001,1,0
0,0,1,0,0,-4,hsa04666,Fc gamma R-mediated phagocytosis,M001,1,0
1,0,0,-2.2,0,0,WP5331,Autophagy in pancreatic ductal adenocarcinoma,M100,1,0
0,1,0,0,-2.5,0,hsa04015,Rap1 signaling pathway,M010,1,0
1,0,0,-2.1,0,0,GO:0071376,cellular response to corticotropin-releasing hormone stimulus,M100,1,0
0,1,0,0,-2.3,0,GO:0048537,mucosa-associated lymphoid tissue development,M010,1,0
0,1,0,0,-2.4,0,GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",M010,1,0
1,0,0,-2.1,0,0,GO:0036438,maintenance of lens transparency,M100,1,0
0,0,1,0,0,-2.6,R-HSA-2730905,Role of LAT2/NTAL/LAB on calcium mobilization,M001,1,0
0,1,0,0,-3.3,0,hsa04940,Type I diabetes mellitus,M010,1,0
0,1,0,0,-3.1,0,GO:0042330,taxis,M010,1,0
1,0,0,-2.1,0,0,GO:0060534,trachea cartilage development,M100,1,0
0,0,1,0,0,-2.6,GO:0010770,positive regulation of cell morphogenesis,M001,1,0
1,0,0,-2.8,0,0,GO:0032909,regulation of transforming growth factor beta2 production,M100,1,0
1,0,0,-2.8,0,0,WP231,TNF alpha signaling pathway,M100,1,0
1,0,0,-2.1,0,0,GO:0006089,lactate metabolic process,M100,1,0
1,0,0,-2.1,0,0,GO:0038159,C-X-C chemokine receptor CXCR4 signaling pathway,M100,1,0
1,0,0,-2.9,0,0,GO:2001054,negative regulation of mesenchymal cell apoptotic process,M100,1,0
0,0,1,0,0,-2.7,GO:0043068,positive regulation of programmed cell death,M001,1,0
0,1,0,0,-2.2,0,GO:1990806,ligand-gated ion channel signaling pathway,M010,1,0
1,0,0,-2.4,0,0,R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,M100,1,0
0,1,0,0,-3,0,GO:0071346,cellular response to type II interferon,M010,1,0
1,0,0,-2.4,0,0,GO:0032330,regulation of chondrocyte differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:0007589,body fluid secretion,M100,1,0
1,0,0,-3,0,0,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,M100,1,0
1,0,0,-2.5,0,0,GO:0048593,camera-type eye morphogenesis,M100,1,0
0,0,1,0,0,-2.1,WP2879,Farnesoid X receptor pathway,M001,1,0
0,0,1,0,0,-2.8,GO:0022030,telencephalon glial cell migration,M001,1,0
0,1,0,0,-2.8,0,GO:0035235,ionotropic glutamate receptor signaling pathway,M010,1,0
0,1,0,0,-2.8,0,GO:0071676,negative regulation of mononuclear cell migration,M010,1,0
0,0,1,0,0,-2.3,R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,M001,1,0
0,1,0,0,-2.1,0,GO:0071229,cellular response to acid chemical,M010,1,0
1,0,0,-2.6,0,0,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,M100,1,0
1,0,0,-2.1,0,0,GO:0014733,regulation of skeletal muscle adaptation,M100,1,0
1,0,0,-2.1,0,0,GO:0002714,positive regulation of B cell mediated immunity,M100,1,0
1,0,0,-3.3,0,0,GO:0002068,glandular epithelial cell development,M100,1,0
0,1,0,0,-2.6,0,R-HSA-6794361,Neurexins and neuroligins,M010,1,0
1,0,0,-2.5,0,0,R-HSA-111997,CaM pathway,M100,1,0
0,1,0,0,-3.8,0,GO:0061551,trigeminal ganglion development,M010,1,0
0,1,0,0,-2.2,0,GO:0120031,plasma membrane bounded cell projection assembly,M010,1,0
0,1,0,0,-2.2,0,GO:0010035,response to inorganic substance,M010,1,0
1,0,0,-3.3,0,0,hsa05160,Hepatitis C,M100,1,0
0,0,1,0,0,-2.9,R-HSA-8939246,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,M001,1,0
0,1,0,0,-2.1,0,GO:0061043,regulation of vascular wound healing,M010,1,0
1,0,0,-2.4,0,0,GO:0006109,regulation of carbohydrate metabolic process,M100,1,0
0,1,0,0,-2.1,0,GO:2001014,regulation of skeletal muscle cell differentiation,M010,1,0
0,1,0,0,-2.2,0,WP4871,Kisspeptin kisspeptin receptor system in the ovary,M010,1,0
0,1,0,0,-2.4,0,hsa05330,Allograft rejection,M010,1,0
1,0,0,-6.2,0,0,R-HSA-383280,Nuclear Receptor transcription pathway,M100,1,0
1,0,0,-2.2,0,0,GO:0002701,negative regulation of production of molecular mediator of immune response,M100,1,0
0,0,1,0,0,-2,GO:0006164,purine nucleotide biosynthetic process,M001,1,0
0,1,0,0,-2.4,0,GO:0002237,response to molecule of bacterial origin,M010,1,0
0,1,0,0,-2.1,0,R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,M010,1,0
0,0,1,0,0,-2.9,R-HSA-8941333,RUNX2 regulates genes involved in differentiation of myeloid cells,M001,1,0
0,0,1,0,0,-2.9,GO:0038001,paracrine signaling,M001,1,0
1,0,0,-2.9,0,0,GO:0035051,cardiocyte differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:0010665,regulation of cardiac muscle cell apoptotic process,M100,1,0
1,0,0,-2.7,0,0,hsa04150,mTOR signaling pathway,M100,1,0
0,1,0,0,-2.1,0,GO:1990138,neuron projection extension,M010,1,0
1,0,0,-2.8,0,0,GO:0010611,regulation of cardiac muscle hypertrophy,M100,1,0
0,0,1,0,0,-2.1,R-HSA-6783783,Interleukin-10 signaling,M001,1,0
1,0,0,-3.6,0,0,GO:1990823,response to leukemia inhibitory factor,M100,1,0
1,0,0,-2.4,0,0,GO:0001889,liver development,M100,1,0
1,0,0,-3.6,0,0,GO:0009267,cellular response to starvation,M100,1,0
1,0,0,-3.6,0,0,R-HSA-9707616,Heme signaling,M100,1,0
1,0,0,-2.5,0,0,hsa04810,Regulation of actin cytoskeleton,M100,1,0
1,0,0,-2.4,0,0,GO:0035329,hippo signaling,M100,1,0
1,0,0,-3.5,0,0,GO:0042269,regulation of natural killer cell mediated cytotoxicity,M100,1,0
1,0,0,-3.4,0,0,GO:0044089,positive regulation of cellular component biogenesis,M100,1,0
0,1,0,0,-3.3,0,WP3931,Embryonic stem cell pluripotency pathways,M010,1,0
1,0,0,-3.5,0,0,R-HSA-9827857,Specification of primordial germ cells,M100,1,0
1,0,0,-4.9,0,0,M162,PID RXR VDR PATHWAY,M100,1,0
0,1,0,0,-2.4,0,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,M010,1,0
0,1,0,0,-2.7,0,GO:0043388,positive regulation of DNA binding,M010,1,0
0,0,1,0,0,-2.3,GO:0030854,positive regulation of granulocyte differentiation,M001,1,0
1,0,0,-3,0,0,WP3594,Circadian rhythm genes,M100,1,0
0,1,0,0,-2,0,GO:0045807,positive regulation of endocytosis,M010,1,0
0,1,0,0,-3.2,0,WP1425,Bone morphogenic protein signaling and regulation,M010,1,0
1,0,0,-2.2,0,0,GO:0035307,positive regulation of protein dephosphorylation,M100,1,0
0,1,0,0,-2.4,0,GO:2000404,regulation of T cell migration,M010,1,0
0,0,1,0,0,-2.6,GO:0021529,spinal cord oligodendrocyte cell differentiation,M001,1,0
1,0,0,-2.1,0,0,GO:0090184,positive regulation of kidney development,M100,1,0
0,1,0,0,-2.2,0,GO:0051592,response to calcium ion,M010,1,0
1,0,0,-2.6,0,0,GO:0150104,transport across blood-brain barrier,M100,1,0
1,0,0,-2.8,0,0,GO:0021877,forebrain neuron fate commitment,M100,1,0
1,0,0,-2.8,0,0,GO:0071635,negative regulation of transforming growth factor beta production,M100,1,0
1,0,0,-2.9,0,0,GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,M100,1,0
1,0,0,-2.1,0,0,GO:0009190,cyclic nucleotide biosynthetic process,M100,1,0
0,1,0,0,-2.1,0,GO:0060070,canonical Wnt signaling pathway,M010,1,0
0,1,0,0,-2.1,0,GO:0040020,regulation of meiotic nuclear division,M010,1,0
0,1,0,0,-2.3,0,GO:0030219,megakaryocyte differentiation,M010,1,0
1,0,0,-2.2,0,0,M220,PID CASPASE PATHWAY,M100,1,0
0,1,0,0,-2.7,0,GO:2000147,positive regulation of cell motility,M010,1,0
0,1,0,0,-2.2,0,GO:0006024,glycosaminoglycan biosynthetic process,M010,1,0
1,0,0,-2.1,0,0,GO:0060976,coronary vasculature development,M100,1,0
1,0,0,-2.8,0,0,GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,M100,1,0
1,0,0,-2.7,0,0,GO:0016331,morphogenesis of embryonic epithelium,M100,1,0
1,0,0,-6.8,0,0,R-HSA-9006931,Signaling by Nuclear Receptors,M100,1,0
1,0,0,-3.4,0,0,GO:0002821,positive regulation of adaptive immune response,M100,1,0
0,1,0,0,-2.1,0,GO:0060576,intestinal epithelial cell development,M010,1,0
0,1,0,0,-2.2,0,GO:0060421,positive regulation of heart growth,M010,1,0
0,1,0,0,-3.1,0,WP4223,Ras signaling,M010,1,0
0,0,1,0,0,-2.9,R-HSA-9674555,Signaling by CSF3 (G-CSF),M001,1,0
1,0,0,-2.6,0,0,WP299,Nuclear receptors in lipid metabolism and toxicity,M100,1,0
1,0,0,-4.2,0,0,R-HSA-8939211,ESR-mediated signaling,M100,1,0
1,0,0,-3,0,0,GO:0030316,osteoclast differentiation,M100,1,0
1,0,0,-3.3,0,0,GO:0043523,regulation of neuron apoptotic process,M100,1,0
1,0,0,-3.4,0,0,GO:0060324,face development,M100,1,0
1,0,0,-3.3,0,0,R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling,M100,1,0
1,0,0,-2.1,0,0,GO:0061626,pharyngeal arch artery morphogenesis,M100,1,0
0,1,0,0,-2.1,0,GO:0045064,T-helper 2 cell differentiation,M010,1,0
1,0,0,-2.5,0,0,GO:0051051,negative regulation of transport,M100,1,0
1,0,0,-2.1,0,0,R-HSA-3645790,TGFBR2 Kinase Domain Mutants in Cancer,M100,1,0
0,1,0,0,-2.2,0,GO:0045446,endothelial cell differentiation,M010,1,0
1,0,0,-2.2,0,0,GO:0051048,negative regulation of secretion,M100,1,0
1,0,0,-2.6,0,0,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,M100,1,0
0,1,0,0,-2.7,0,R-HSA-9012852,Signaling by NOTCH3,M010,1,0
1,0,0,-2.8,0,0,GO:0060251,regulation of glial cell proliferation,M100,1,0
0,1,0,0,-2.2,0,GO:0006023,aminoglycan biosynthetic process,M010,1,0
1,0,0,-3.2,0,0,GO:0051384,response to glucocorticoid,M100,1,0
0,0,1,0,0,-2.6,GO:0046533,negative regulation of photoreceptor cell differentiation,M001,1,0
0,1,0,0,-2.1,0,R-HSA-9020958,Interleukin-21 signaling,M010,1,0
1,0,0,-2.1,0,0,GO:0001821,histamine secretion,M100,1,0
0,1,0,0,-2.6,0,GO:0002501,peptide antigen assembly with MHC protein complex,M010,1,0
1,0,0,-2.1,0,0,WP3593,MicroRNA for targeting cancer growth and vascularization in glioblastoma,M100,1,0
0,0,1,0,0,-2.3,GO:0030852,regulation of granulocyte differentiation,M001,1,0
0,1,0,0,-3,0,WP3303,RAC1 PAK1 p38 MMP2 pathway,M010,1,0
1,0,0,-5.6,0,0,GO:0010562,positive regulation of phosphorus metabolic process,M100,1,0
1,0,0,-2.9,0,0,GO:0043301,negative regulation of leukocyte degranulation,M100,1,0
1,0,0,-2.5,0,0,GO:0010922,positive regulation of phosphatase activity,M100,1,0
1,0,0,-2.8,0,0,GO:0042594,response to starvation,M100,1,0
1,0,0,-2.2,0,0,GO:0009746,response to hexose,M100,1,0
0,0,1,0,0,-4.2,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,M001,1,0
0,1,0,0,-2.4,0,GO:0035162,embryonic hemopoiesis,M010,1,0
0,1,0,0,-3.9,0,GO:0010975,regulation of neuron projection development,M010,1,0
0,1,0,0,-3,0,WP3893,Development and heterogeneity of the ILC family,M010,1,0
0,1,0,0,-2.4,0,GO:0001937,negative regulation of endothelial cell proliferation,M010,1,0
1,0,0,-4.7,0,0,GO:0002716,negative regulation of natural killer cell mediated immunity,M100,1,0
0,1,0,0,-2,0,R-HSA-1912422,Pre-NOTCH Expression and Processing,M010,1,0
1,0,0,-4.4,0,0,hsa05216,Thyroid cancer,M100,1,0
1,0,0,-2.1,0,0,R-HSA-909733,Interferon alpha/beta signaling,M100,1,0
0,1,0,0,-2.4,0,GO:0046622,positive regulation of organ growth,M010,1,0
0,1,0,0,-2.6,0,GO:0051046,regulation of secretion,M010,1,0
0,1,0,0,-2.3,0,GO:0071316,cellular response to nicotine,M010,1,0
1,0,0,-2.1,0,0,GO:0001714,endodermal cell fate specification,M100,1,0
0,1,0,0,-2.9,0,GO:0060686,negative regulation of prostatic bud formation,M010,1,0
0,1,0,0,-3.4,0,GO:0071675,regulation of mononuclear cell migration,M010,1,0
1,0,0,-7.1,0,0,GO:0030522,intracellular receptor signaling pathway,M100,1,0
0,1,0,0,-2.3,0,hsa04014,Ras signaling pathway,M010,1,0
0,1,0,0,-2.3,0,GO:0097531,mast cell migration,M010,1,0
1,0,0,-2.8,0,0,R-HSA-112313,Neurotransmitter uptake and metabolism In glial cells,M100,1,0
0,0,1,0,0,-3.6,R-HSA-109582,Hemostasis,M001,1,0
1,0,0,-2.4,0,0,GO:0010885,regulation of cholesterol storage,M100,1,0
1,0,0,-2.1,0,0,GO:1904151,positive regulation of microglial cell mediated cytotoxicity,M100,1,0
0,1,0,0,-3,0,R-HSA-5621481,C-type lectin receptors (CLRs),M010,1,0
0,1,0,0,-2.4,0,GO:0099565,"chemical synaptic transmission, postsynaptic",M010,1,0
1,0,0,-3.6,0,0,GO:0060351,cartilage development involved in endochondral bone morphogenesis,M100,1,0
0,1,0,0,-3.3,0,GO:0043586,tongue development,M010,1,0
1,0,0,-3.6,0,0,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,M100,1,0
0,1,0,0,-2.9,0,R-HSA-9664420,Killing mechanisms,M010,1,0
0,1,0,0,-2.6,0,GO:0021955,central nervous system neuron axonogenesis,M010,1,0
1,0,0,-2.1,0,0,GO:0035385,Roundabout signaling pathway,M100,1,0
1,0,0,-2.2,0,0,GO:0001706,endoderm formation,M100,1,0
1,0,0,-2.1,0,0,GO:0001842,neural fold formation,M100,1,0
0,1,0,0,-2.4,0,GO:0043408,regulation of MAPK cascade,M010,1,0
1,0,0,-2.7,0,0,GO:0007015,actin filament organization,M100,1,0
1,0,0,-2.7,0,0,GO:0032480,negative regulation of type I interferon production,M100,1,0
0,1,0,0,-3.1,0,GO:1901222,regulation of non-canonical NF-kappaB signal transduction,M010,1,0
0,1,0,0,-4.4,0,GO:0048596,embryonic camera-type eye morphogenesis,M010,1,0
0,1,0,0,-3.5,0,GO:1990869,cellular response to chemokine,M010,1,0
1,0,0,-2.1,0,0,R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,M100,1,0
0,1,0,0,-2,0,GO:0051445,regulation of meiotic cell cycle,M010,1,0
1,0,0,-2.1,0,0,GO:0110024,positive regulation of cardiac muscle myoblast proliferation,M100,1,0
0,1,0,0,-2.8,0,GO:0071697,ectodermal placode morphogenesis,M010,1,0
0,1,0,0,-2.1,0,GO:0021610,facial nerve morphogenesis,M010,1,0
0,1,0,0,-2.7,0,GO:0048675,axon extension,M010,1,0
0,1,0,0,-2.5,0,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),M010,1,0
0,0,1,0,0,-2.6,GO:0019359,nicotinamide nucleotide biosynthetic process,M001,1,0
0,0,1,0,0,-2,GO:0006886,intracellular protein transport,M001,1,0
1,0,0,-2.1,0,0,R-HSA-163615,PKA activation,M100,1,0
1,0,0,-2.4,0,0,R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,M100,1,0
1,0,0,-3.5,0,0,GO:0003018,vascular process in circulatory system,M100,1,0
0,0,1,0,0,-2.4,WP5348,11p11 2 copy number variation syndrome,M001,1,0
1,0,0,-2.2,0,0,GO:0009743,response to carbohydrate,M100,1,0
1,0,0,-3.4,0,0,R-HSA-8941855,RUNX3 regulates CDKN1A transcription,M100,1,0
1,0,0,-3.8,0,0,GO:0035019,somatic stem cell population maintenance,M100,1,0
0,1,0,0,-3.8,0,WP4262,Breast cancer pathway,M010,1,0
1,0,0,-3.3,0,0,R-HSA-1368108,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",M100,1,0
1,0,0,-2.1,0,0,GO:1901256,regulation of macrophage colony-stimulating factor production,M100,1,0
1,0,0,-2.4,0,0,GO:0008286,insulin receptor signaling pathway,M100,1,0
1,0,0,-2.1,0,0,GO:0090190,positive regulation of branching involved in ureteric bud morphogenesis,M100,1,0
1,0,0,-2.1,0,0,GO:0035283,central nervous system segmentation,M100,1,0
1,0,0,-2.1,0,0,GO:0042118,endothelial cell activation,M100,1,0
1,0,0,-2.4,0,0,WP98,Prostaglandin synthesis and regulation,M100,1,0
1,0,0,-2.5,0,0,GO:0035883,enteroendocrine cell differentiation,M100,1,0
1,0,0,-2.6,0,0,GO:0050919,negative chemotaxis,M100,1,0
1,0,0,-2,0,0,GO:0050673,epithelial cell proliferation,M100,1,0
1,0,0,-2.1,0,0,GO:0030100,regulation of endocytosis,M100,1,0
0,1,0,0,-3.6,0,GO:0034341,response to type II interferon,M010,1,0
1,0,0,-2.4,0,0,GO:0002709,regulation of T cell mediated immunity,M100,1,0
1,0,0,-2,0,0,GO:0042742,defense response to bacterium,M100,1,0
0,1,0,0,-2.4,0,GO:0009620,response to fungus,M010,1,0
0,1,0,0,-2.8,0,GO:0002503,peptide antigen assembly with MHC class II protein complex,M010,1,0
0,1,0,0,-2.4,0,R-HSA-1169091,Activation of NF-kappaB in B cells,M010,1,0
1,0,0,-2.3,0,0,GO:0003161,cardiac conduction system development,M100,1,0
1,0,0,-2.4,0,0,GO:0099537,trans-synaptic signaling,M100,1,0
0,1,0,0,-2,0,GO:0009913,epidermal cell differentiation,M010,1,0
1,0,0,-2.3,0,0,GO:0032869,cellular response to insulin stimulus,M100,1,0
1,0,0,-2.1,0,0,GO:0002891,positive regulation of immunoglobulin mediated immune response,M100,1,0
0,0,1,0,0,-4,GO:0038094,Fc-gamma receptor signaling pathway,M001,1,0
1,0,0,-2.1,0,0,GO:0002774,Fc receptor mediated inhibitory signaling pathway,M100,1,0
1,0,0,-6,0,0,GO:0043434,response to peptide hormone,M100,1,0
0,1,0,0,-3,0,WP4539,Synaptic signaling pathways associated with autism spectrum disorder,M010,1,0
1,0,0,-2.5,0,0,GO:1900542,regulation of purine nucleotide metabolic process,M100,1,0
1,0,0,-4.2,0,0,GO:0003416,endochondral bone growth,M100,1,0
0,1,0,0,-2.5,0,GO:0061245,establishment or maintenance of bipolar cell polarity,M010,1,0
1,0,0,-2.2,0,0,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",M100,1,0
0,1,0,0,-3.2,0,GO:1904893,negative regulation of receptor signaling pathway via STAT,M010,1,0
1,0,0,-2.1,0,0,GO:0006171,cAMP biosynthetic process,M100,1,0
1,0,0,-3.2,0,0,GO:1990830,cellular response to leukemia inhibitory factor,M100,1,0
1,0,0,-2.8,0,0,GO:0042593,glucose homeostasis,M100,1,0
1,0,0,-3.4,0,0,M58,PID AR PATHWAY,M100,1,0
0,1,0,0,-3.6,0,R-HSA-202403,TCR signaling,M010,1,0
1,0,0,-2.1,0,0,GO:0021826,substrate-independent telencephalic tangential migration,M100,1,0
0,1,0,0,-2.4,0,WP5092,Interactions of natural killer cells in pancreatic cancer,M010,1,0
0,0,1,0,0,-3.3,WP4564,Neural crest cell migration during development,M001,1,0
1,0,0,-2.5,0,0,WP4830,GDNF RET signaling axis,M100,1,0
0,0,1,0,0,-2.1,GO:0043065,positive regulation of apoptotic process,M001,1,0
0,0,1,0,0,-2.2,GO:0006606,protein import into nucleus,M001,1,0
1,0,0,-2.2,0,0,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,M100,1,0
1,0,0,-2.1,0,0,GO:0003299,muscle hypertrophy in response to stress,M100,1,0
1,0,0,-2.1,0,0,R-HSA-452723,Transcriptional regulation of pluripotent stem cells,M100,1,0
1,0,0,-3.2,0,0,GO:0032720,negative regulation of tumor necrosis factor production,M100,1,0
1,0,0,-6,0,0,GO:2000629,negative regulation of miRNA metabolic process,M100,1,0
0,0,1,0,0,-2.7,GO:0018212,peptidyl-tyrosine modification,M001,1,0
1,0,0,-2.4,0,0,GO:0010039,response to iron ion,M100,1,0
0,0,1,0,0,-2.7,WP5044,Kynurenine pathway and links to cell senescence,M001,1,0
1,0,0,-2.6,0,0,GO:0003203,endocardial cushion morphogenesis,M100,1,0
1,0,0,-2,0,0,GO:0034284,response to monosaccharide,M100,1,0
1,0,0,-3.4,0,0,R-HSA-9823739,Formation of the anterior neural plate,M100,1,0
0,0,1,0,0,-2.7,GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,M001,1,0
0,0,1,0,0,-2.1,R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,M001,1,0
1,0,0,-2.1,0,0,GO:0046879,hormone secretion,M100,1,0
1,0,0,-2.1,0,0,GO:0002767,immune response-inhibiting cell surface receptor signaling pathway,M100,1,0
0,0,1,0,0,-2.1,GO:0072109,glomerular mesangium development,M001,1,0
1,0,0,-2.8,0,0,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,M100,1,0
1,0,0,-2.1,0,0,GO:0003418,growth plate cartilage chondrocyte differentiation,M100,1,0
1,0,0,-3.2,0,0,GO:0048738,cardiac muscle tissue development,M100,1,0
1,0,0,-2.1,0,0,hsa04714,Thermogenesis,M100,1,0
1,0,0,-2.1,0,0,GO:1902256,regulation of apoptotic process involved in outflow tract morphogenesis,M100,1,0
1,0,0,-2.8,0,0,GO:0034135,regulation of toll-like receptor 2 signaling pathway,M100,1,0
1,0,0,-2.9,0,0,GO:0097190,apoptotic signaling pathway,M100,1,0
1,0,0,-2.1,0,0,CORUM:3027,TGF-beta receptor II-TGF-beta receptor I-TGF-beta1 complex,M100,1,0
0,1,0,0,-3.2,0,GO:0048015,phosphatidylinositol-mediated signaling,M010,1,0
0,0,1,0,0,-2.7,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,M001,1,0
0,0,1,0,0,-2.4,GO:0006909,phagocytosis,M001,1,0
1,0,0,-2.2,0,0,GO:0050672,negative regulation of lymphocyte proliferation,M100,1,0
0,0,1,0,0,-2.3,GO:0031334,positive regulation of protein-containing complex assembly,M001,1,0
1,0,0,-2.6,0,0,GO:0010232,vascular transport,M100,1,0
1,0,0,-2.1,0,0,GO:0021830,interneuron migration from the subpallium to the cortex,M100,1,0
0,1,0,0,-2.4,0,GO:0034110,regulation of homotypic cell-cell adhesion,M010,1,0
0,1,0,0,-2.3,0,CORUM:5194,"TNF-alpha/NF-kappa B signaling complex (SEC16A, CHUK, IKBKB, NFKB2, REL, IKBKG, MAP3K14, RELA, FBXW7, USP2)",M010,1,0
0,0,1,0,0,-2.1,GO:0048934,peripheral nervous system neuron differentiation,M001,1,0
1,0,0,-3.2,0,0,R-HSA-1489509,DAG and IP3 signaling,M100,1,0
1,0,0,-2.1,0,0,GO:0010171,body morphogenesis,M100,1,0
0,1,0,0,-2.6,0,GO:0071354,cellular response to interleukin-6,M010,1,0
0,1,0,0,-2.6,0,hsa04066,HIF-1 signaling pathway,M010,1,0
0,1,0,0,-2,0,GO:0045931,positive regulation of mitotic cell cycle,M010,1,0
1,0,0,-4.1,0,0,WP2435,Quercetin and Nf kB AP 1 induced apoptosis,M100,1,0
0,0,1,0,0,-2.2,GO:0035418,protein localization to synapse,M001,1,0
0,1,0,0,-2.9,0,R-HSA-8849932,Synaptic adhesion-like molecules,M010,1,0
0,1,0,0,-2.2,0,GO:0007163,establishment or maintenance of cell polarity,M010,1,0
1,0,0,-2,0,0,hsa05205,Proteoglycans in cancer,M100,1,0
0,0,1,0,0,-2.1,GO:0060425,lung morphogenesis,M001,1,0
0,1,0,0,-2.7,0,M100,PID SHP2 PATHWAY,M010,1,0
1,0,0,-3,0,0,GO:1901203,positive regulation of extracellular matrix assembly,M100,1,0
0,1,0,0,-2.2,0,GO:1900274,regulation of phospholipase C activity,M010,1,0
1,0,0,-5.7,0,0,GO:0070482,response to oxygen levels,M100,1,0
0,0,1,0,0,-2.1,GO:0050871,positive regulation of B cell activation,M001,1,0
0,1,0,0,-3,0,GO:0032703,negative regulation of interleukin-2 production,M010,1,0
1,0,0,-2.1,0,0,WP5199,PtdIns 4 5 P2 in cytokinesis pathway,M100,1,0
1,0,0,-2.7,0,0,GO:0034762,regulation of transmembrane transport,M100,1,0
1,0,0,-2.4,0,0,R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",M100,1,0
0,0,1,0,0,-3.1,M91,PID TCPTP PATHWAY,M001,1,0
0,0,1,0,0,-3.3,WP4565,Neural crest cell migration in cancer,M001,1,0
0,1,0,0,-2.4,0,GO:0046660,female sex differentiation,M010,1,0
1,0,0,-2.3,0,0,GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation",M100,1,0
1,0,0,-2,0,0,hsa04932,Non-alcoholic fatty liver disease,M100,1,0
1,0,0,-2.3,0,0,GO:0030889,negative regulation of B cell proliferation,M100,1,0
1,0,0,-2.2,0,0,GO:0002507,tolerance induction,M100,1,0
0,0,1,0,0,-2.2,WP5074,Kallmann syndrome,M001,1,0
1,0,0,-2.3,0,0,R-HSA-877300,Interferon gamma signaling,M100,1,0
1,0,0,-2.7,0,0,M5193,SIG CHEMOTAXIS,M100,1,0
1,0,0,-2.4,0,0,R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,M100,1,0
1,0,0,-2.1,0,0,GO:0021894,cerebral cortex GABAergic interneuron development,M100,1,0
1,0,0,-3.5,0,0,GO:0071496,cellular response to external stimulus,M100,1,0
1,0,0,-5.3,0,0,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,M100,1,0
0,0,1,0,0,-2.1,GO:1902414,protein localization to cell junction,M001,1,0
0,1,0,0,-2.6,0,WP4155,Endometrial cancer,M010,1,0
1,0,0,-2.2,0,0,R-HSA-975871,MyD88 cascade initiated on plasma membrane,M100,1,0
1,0,0,-2.1,0,0,GO:0003430,growth plate cartilage chondrocyte growth,M100,1,0
0,1,0,0,-3.1,0,GO:0006935,chemotaxis,M010,1,0
0,1,0,0,-2.4,0,GO:0030335,positive regulation of cell migration,M010,1,0
1,0,0,-2.3,0,0,GO:0010887,negative regulation of cholesterol storage,M100,1,0
0,1,0,0,-2.3,0,GO:0051127,positive regulation of actin nucleation,M010,1,0
0,0,1,0,0,-2,GO:0045649,regulation of macrophage differentiation,M001,1,0
1,0,0,-3,0,0,GO:0042789,mRNA transcription by RNA polymerase II,M100,1,0
0,1,0,0,-2.3,0,GO:2001056,positive regulation of cysteine-type endopeptidase activity,M010,1,0
0,1,0,0,-2.7,0,R-HSA-201681,TCF dependent signaling in response to WNT,M010,1,0
0,1,0,0,-2.2,0,GO:0071774,response to fibroblast growth factor,M010,1,0
0,1,0,0,-3.2,0,WP5284,Cell interactions of the pancreatic cancer microenvironment,M010,1,0
0,1,0,0,-2.6,0,GO:0043200,response to amino acid,M010,1,0
0,1,0,0,-2.8,0,GO:0072074,kidney mesenchyme development,M010,1,0
1,0,0,-2.1,0,0,GO:0045926,negative regulation of growth,M100,1,0
0,1,0,0,-2.3,0,GO:0035470,positive regulation of vascular wound healing,M010,1,0
0,1,0,0,-3.6,0,GO:0060078,regulation of postsynaptic membrane potential,M010,1,0
1,0,0,-3.2,0,0,GO:0031669,cellular response to nutrient levels,M100,1,0
0,1,0,0,-2.9,0,GO:0032765,positive regulation of mast cell cytokine production,M010,1,0
0,1,0,0,-2.8,0,GO:0009100,glycoprotein metabolic process,M010,1,0
1,0,0,-2.1,0,0,GO:0002238,response to molecule of fungal origin,M100,1,0
0,1,0,0,-2.4,0,hsa05230,Central carbon metabolism in cancer,M010,1,0
0,1,0,0,-2.3,0,R-HSA-202424,Downstream TCR signaling,M010,1,0
1,0,0,-2.1,0,0,GO:0033630,positive regulation of cell adhesion mediated by integrin,M100,1,0
1,0,0,-2.1,0,0,R-HSA-3656535,TGFBR1 LBD Mutants in Cancer,M100,1,0
0,1,0,0,-2.7,0,GO:1905330,regulation of morphogenesis of an epithelium,M010,1,0
1,0,0,-6.4,0,0,WP170,Nuclear receptors,M100,1,0
1,0,0,-3,0,0,GO:0031667,response to nutrient levels,M100,1,0
0,1,0,0,-2.7,0,GO:0003158,endothelium development,M010,1,0
1,0,0,-2.1,0,0,GO:0002519,natural killer cell tolerance induction,M100,1,0
1,0,0,-2.1,0,0,CORUM:1890,ELK1-SRF-ELK4 complex,M100,1,0
1,0,0,-2.5,0,0,WP3298,Melatonin metabolism and effects,M100,1,0
0,1,0,0,-2.6,0,GO:0030111,regulation of Wnt signaling pathway,M010,1,0
0,1,0,0,-2.1,0,GO:0032814,regulation of natural killer cell activation,M010,1,0
0,0,1,0,0,-5.4,GO:0019221,cytokine-mediated signaling pathway,M001,1,0
1,0,0,-2.1,0,0,R-HSA-3656534,Loss of Function of TGFBR1 in Cancer,M100,1,0
0,1,0,0,-2.9,0,GO:0001707,mesoderm formation,M010,1,0
1,0,0,-4,0,0,GO:0032868,response to insulin,M100,1,0
0,1,0,0,-2.4,0,GO:0070741,response to interleukin-6,M010,1,0
1,0,0,-2.8,0,0,GO:0071300,cellular response to retinoic acid,M100,1,0
0,1,0,0,-2.4,0,GO:0007494,midgut development,M010,1,0
0,1,0,0,-2.8,0,GO:0060788,ectodermal placode formation,M010,1,0
0,1,0,0,-2.6,0,GO:0051338,regulation of transferase activity,M010,1,0
0,1,0,0,-2.1,0,GO:0071466,cellular response to xenobiotic stimulus,M010,1,0
1,0,0,-2.1,0,0,WP2249,Metastatic brain tumor,M100,1,0
1,0,0,-2,0,0,GO:0032570,response to progesterone,M100,1,0
0,1,0,0,-2.2,0,GO:0000302,response to reactive oxygen species,M010,1,0
0,1,0,0,-2.1,0,GO:0034114,regulation of heterotypic cell-cell adhesion,M010,1,0
1,0,0,-2.1,0,0,GO:0002477,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,M100,1,0
1,0,0,-2.4,0,0,GO:0070169,positive regulation of biomineral tissue development,M100,1,0
0,1,0,0,-3,0,GO:0032495,response to muramyl dipeptide,M010,1,0
0,1,0,0,-2.2,0,R-HSA-5684996,MAPK1/MAPK3 signaling,M010,1,0
1,0,0,-2.3,0,0,GO:0034616,response to laminar fluid shear stress,M100,1,0
1,0,0,-2.8,0,0,GO:0090257,regulation of muscle system process,M100,1,0
0,1,0,0,-2.9,0,GO:0099566,regulation of postsynaptic cytosolic calcium ion concentration,M010,1,0
0,1,0,0,-2.3,0,GO:0051660,establishment of centrosome localization,M010,1,0
0,1,0,0,-2.2,0,GO:0046885,regulation of hormone biosynthetic process,M010,1,0
1,0,0,-3.2,0,0,R-HSA-445717,Aquaporin-mediated transport,M100,1,0
0,1,0,0,-4.2,0,WP4787,Osteoblast differentiation and related diseases,M010,1,0
1,0,0,-2.5,0,0,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M100,1,0
1,0,0,-4.7,0,0,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M100,1,0
0,1,0,0,-3.7,0,GO:0140352,export from cell,M010,1,0
0,1,0,0,-2.4,0,GO:0032928,regulation of superoxide anion generation,M010,1,0
1,0,0,-2.8,0,0,GO:0001914,regulation of T cell mediated cytotoxicity,M100,1,0
1,0,0,-3,0,0,GO:0002719,negative regulation of cytokine production involved in immune response,M100,1,0
0,1,0,0,-2.6,0,GO:0038084,vascular endothelial growth factor signaling pathway,M010,1,0
1,0,0,-2.5,0,0,GO:1903531,negative regulation of secretion by cell,M100,1,0
0,1,0,0,-2.5,0,R-HSA-195721,Signaling by WNT,M010,1,0
0,1,0,0,-3.2,0,GO:0061550,cranial ganglion development,M010,1,0
1,0,0,-2.7,0,0,GO:0062012,regulation of small molecule metabolic process,M100,1,0
1,0,0,-2.9,0,0,R-HSA-163359,Glucagon signaling in metabolic regulation,M100,1,0
1,0,0,-2.1,0,0,GO:1902460,regulation of mesenchymal stem cell proliferation,M100,1,0
1,0,0,-2.3,0,0,GO:0034764,positive regulation of transmembrane transport,M100,1,0
0,1,0,0,-2.9,0,GO:0030910,olfactory placode formation,M010,1,0
1,0,0,-3,0,0,hsa04724,Glutamatergic synapse,M100,1,0
0,1,0,0,-2.9,0,GO:0030513,positive regulation of BMP signaling pathway,M010,1,0
0,1,0,0,-4.2,0,GO:0031175,neuron projection development,M010,1,0
1,0,0,-3.1,0,0,GO:0010662,regulation of striated muscle cell apoptotic process,M100,1,0
1,0,0,-2.8,0,0,WP3407,FTO obesity variant mechanism,M100,1,0
1,0,0,-2.8,0,0,WP254,Apoptosis,M100,1,0
0,1,0,0,-3.7,0,R-HSA-5607764,CLEC7A (Dectin-1) signaling,M010,1,0
1,0,0,-2.6,0,0,GO:0016444,somatic cell DNA recombination,M100,1,0
0,0,1,0,0,-2.4,GO:0034113,heterotypic cell-cell adhesion,M001,1,0
0,1,0,0,-3,0,GO:0035249,"synaptic transmission, glutamatergic",M010,1,0
0,1,0,0,-2.3,0,GO:0003073,regulation of systemic arterial blood pressure,M010,1,0
1,0,0,-2.1,0,0,R-HSA-111931,PKA-mediated phosphorylation of CREB,M100,1,0
1,0,0,-4.4,0,0,GO:0002861,regulation of inflammatory response to antigenic stimulus,M100,1,0
0,1,0,0,-2.3,0,GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,M010,1,0
0,1,0,0,-2.2,0,GO:0042832,defense response to protozoan,M010,1,0
0,1,0,0,-2.1,0,GO:0031929,TOR signaling,M010,1,0
0,1,0,0,-2.7,0,GO:0006887,exocytosis,M010,1,0
0,0,1,0,0,-2.2,GO:0045862,positive regulation of proteolysis,M001,1,0
0,1,0,0,-2.4,0,GO:0050856,regulation of T cell receptor signaling pathway,M010,1,0
1,0,0,-2.5,0,0,GO:0006140,regulation of nucleotide metabolic process,M100,1,0
0,1,0,0,-3,0,GO:0009101,glycoprotein biosynthetic process,M010,1,0
0,1,0,0,-2.1,0,GO:2000146,negative regulation of cell motility,M010,1,0
0,1,0,0,-2.1,0,GO:0045055,regulated exocytosis,M010,1,0
1,0,0,-3.6,0,0,WP2895,Differentiation of white and brown adipocyte,M100,1,0
1,0,0,-2.1,0,0,R-HSA-168898,Toll-like Receptor Cascades,M100,1,0
0,1,0,0,-3.3,0,R-HSA-8986944,Transcriptional Regulation by MECP2,M010,1,0
1,0,0,-2.7,0,0,GO:0007492,endoderm development,M100,1,0
0,1,0,0,-3.4,0,GO:0048332,mesoderm morphogenesis,M010,1,0
0,1,0,0,-2.3,0,WP4906,3q29 copy number variation syndrome,M010,1,0
1,0,0,-2.1,0,0,GO:0010921,regulation of phosphatase activity,M100,1,0
1,0,0,-3.8,0,0,GO:0002706,regulation of lymphocyte mediated immunity,M100,1,0
1,0,0,-3.1,0,0,hsa05225,Hepatocellular carcinoma,M100,1,0
0,1,0,0,-2.3,0,GO:0072106,regulation of ureteric bud formation,M010,1,0
0,1,0,0,-2.1,0,GO:0060602,branch elongation of an epithelium,M010,1,0
0,1,0,0,-3.5,0,GO:0048639,positive regulation of developmental growth,M010,1,0
1,0,0,-2.3,0,0,R-HSA-9707564,Cytoprotection by HMOX1,M100,1,0
1,0,0,-5.6,0,0,GO:0045937,positive regulation of phosphate metabolic process,M100,1,0
0,0,1,0,0,-2.9,GO:1900017,positive regulation of cytokine production involved in inflammatory response,M001,1,0
0,1,0,0,-2.3,0,GO:0032873,negative regulation of stress-activated MAPK cascade,M010,1,0
1,0,0,-2.4,0,0,GO:0046847,filopodium assembly,M100,1,0
0,1,0,0,-2,0,GO:0061041,regulation of wound healing,M010,1,0
1,0,0,-2.1,0,0,GO:0032252,secretory granule localization,M100,1,0
0,0,1,0,0,-2.3,GO:0007160,cell-matrix adhesion,M001,1,0
1,0,0,-2.8,0,0,GO:0062197,cellular response to chemical stress,M100,1,0
0,1,0,0,-2.4,0,R-HSA-948021,Transport to the Golgi and subsequent modification,M010,1,0
0,0,1,0,0,-2.2,WP313,Hepatocyte growth factor receptor signaling,M001,1,0
0,1,0,0,-2.1,0,WP3877,MYD88 distinct input output pathway,M010,1,0
1,0,0,-2.1,0,0,GO:0090209,negative regulation of triglyceride metabolic process,M100,1,0
1,0,0,-2.1,0,0,CORUM:2529,"LAT-PLC-gamma-1-p85-GRB2-CBL-VAV-SLP-76 signaling complex, C305 activated",M100,1,0
1,0,0,-2.3,0,0,GO:0001711,endodermal cell fate commitment,M100,1,0
1,0,0,-2.2,0,0,GO:0031960,response to corticosteroid,M100,1,0
1,0,0,-2.8,0,0,GO:0021761,limbic system development,M100,1,0
0,1,0,0,-3.9,0,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,M010,1,0
0,0,1,0,0,-2.3,GO:0043383,negative T cell selection,M001,1,0
1,0,0,-2.4,0,0,GO:0014823,response to activity,M100,1,0
1,0,0,-3.3,0,0,GO:0014741,negative regulation of muscle hypertrophy,M100,1,0
1,0,0,-2.2,0,0,GO:0008016,regulation of heart contraction,M100,1,0
0,1,0,0,-2.1,0,GO:0045576,mast cell activation,M010,1,0
0,1,0,0,-3,0,GO:0071222,cellular response to lipopolysaccharide,M010,1,0
1,0,0,-2.1,0,0,GO:1903689,"regulation of wound healing, spreading of epidermal cells",M100,1,0
0,1,0,0,-2.3,0,GO:0061311,cell surface receptor signaling pathway involved in heart development,M010,1,0
0,0,1,0,0,-2.8,GO:0031295,T cell costimulation,M001,1,0
1,0,0,-2.8,0,0,GO:0106030,neuron projection fasciculation,M100,1,0
0,0,1,0,0,-3.1,GO:0021799,cerebral cortex radially oriented cell migration,M001,1,0
0,0,1,0,0,-2.7,M50,PID PTP1B PATHWAY,M001,1,0
0,0,1,0,0,-2.9,GO:0030222,eosinophil differentiation,M001,1,0
1,0,0,-2.1,0,0,R-HSA-9632974,NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis,M100,1,0
1,0,0,-3.7,0,0,GO:0098868,bone growth,M100,1,0
1,0,0,-5.2,0,0,GO:0036293,response to decreased oxygen levels,M100,1,0
0,0,1,0,0,-3.5,hsa05135,Yersinia infection,M001,1,0
0,1,0,0,-2.3,0,GO:1905222,atrioventricular canal morphogenesis,M010,1,0
1,0,0,-2.3,0,0,R-HSA-1236977,Endosomal/Vacuolar pathway,M100,1,0
0,0,1,0,0,-2,GO:0033673,negative regulation of kinase activity,M001,1,0
1,0,0,-4.2,0,0,GO:0051402,neuron apoptotic process,M100,1,0
1,0,0,-3.2,0,0,GO:0051153,regulation of striated muscle cell differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:0046016,positive regulation of transcription by glucose,M100,1,0
0,1,0,0,-3.8,0,WP5398,NRXN1 deletion syndrome,M010,1,0
1,0,0,-3.5,0,0,GO:0031668,cellular response to extracellular stimulus,M100,1,0
1,0,0,-3.6,0,0,M65,PID FRA PATHWAY,M100,1,0
0,1,0,0,-2.2,0,GO:0035994,response to muscle stretch,M010,1,0
0,1,0,0,-2.3,0,WP4562,Canonical NF kB pathway,M010,1,0
1,0,0,-3.2,0,0,GO:0035270,endocrine system development,M100,1,0
1,0,0,-3,0,0,GO:0060612,adipose tissue development,M100,1,0
1,0,0,-3.1,0,0,GO:0006959,humoral immune response,M100,1,0
1,0,0,-2.4,0,0,GO:2001259,positive regulation of cation channel activity,M100,1,0
0,1,0,0,-2.8,0,hsa05322,Systemic lupus erythematosus,M010,1,0
1,0,0,-2.4,0,0,GO:0002675,positive regulation of acute inflammatory response,M100,1,0
0,0,1,0,0,-2.3,GO:0002431,Fc receptor mediated stimulatory signaling pathway,M001,1,0
0,0,1,0,0,-3.1,R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,M001,1,0
0,1,0,0,-2.8,0,GO:0050852,T cell receptor signaling pathway,M010,1,0
1,0,0,-2.6,0,0,GO:0070301,cellular response to hydrogen peroxide,M100,1,0
1,0,0,-2.1,0,0,GO:0001656,metanephros development,M100,1,0
1,0,0,-4.8,0,0,R-HSA-400253,Circadian Clock,M100,1,0
1,0,0,-2.3,0,0,M121,PID MTOR 4PATHWAY,M100,1,0
1,0,0,-2.2,0,0,GO:2000116,regulation of cysteine-type endopeptidase activity,M100,1,0
1,0,0,-2.2,0,0,R-HSA-9772573,Late SARS-CoV-2 Infection Events,M100,1,0
1,0,0,-4,0,0,GO:0003281,ventricular septum development,M100,1,0
0,1,0,0,-4.2,0,GO:0010463,mesenchymal cell proliferation,M010,1,0
0,0,1,0,0,-3.5,R-HSA-8939247,RUNX1 regulates transcription of genes involved in interleukin signaling,M001,1,0
0,1,0,0,-3.7,0,GO:0010517,regulation of phospholipase activity,M010,1,0
1,0,0,-2.1,0,0,GO:0001756,somitogenesis,M100,1,0
1,0,0,-2.7,0,0,R-HSA-1368082,RORA activates gene expression,M100,1,0
1,0,0,-2.1,0,0,CORUM:3031,Microprocessor complex,M100,1,0
1,0,0,-3.2,0,0,GO:0043502,regulation of muscle adaptation,M100,1,0
0,1,0,0,-2.4,0,GO:0032496,response to lipopolysaccharide,M010,1,0
0,1,0,0,-2.4,0,R-HSA-6794362,Protein-protein interactions at synapses,M010,1,0
0,0,1,0,0,-3.6,WP4698,Vitamin D sensitive calcium signaling in depression,M001,1,0
1,0,0,-2,0,0,GO:0045581,negative regulation of T cell differentiation,M100,1,0
1,0,0,-2.7,0,0,GO:0002244,hematopoietic progenitor cell differentiation,M100,1,0
0,0,1,0,0,-2.8,GO:0009954,proximal/distal pattern formation,M001,1,0
1,0,0,-2.1,0,0,CORUM:1372,Rb-tal-1-E2A-Lmo2-Ldb1 complex,M100,1,0
0,0,1,0,0,-2.6,GO:0046532,regulation of photoreceptor cell differentiation,M001,1,0
0,1,0,0,-2.7,0,GO:0048340,paraxial mesoderm morphogenesis,M010,1,0
0,0,1,0,0,-2.1,GO:0007612,learning,M001,1,0
1,0,0,-4.4,0,0,GO:0007179,transforming growth factor beta receptor signaling pathway,M100,1,0
0,0,1,0,0,-2.4,GO:0033077,T cell differentiation in thymus,M001,1,0
0,1,0,0,-2.1,0,GO:1900006,positive regulation of dendrite development,M010,1,0
1,0,0,-2.3,0,0,R-HSA-9733709,Cardiogenesis,M100,1,0
0,1,0,0,-3.3,0,GO:1904892,regulation of receptor signaling pathway via STAT,M010,1,0
1,0,0,-3,0,0,GO:0032731,positive regulation of interleukin-1 beta production,M100,1,0
1,0,0,-2.7,0,0,R-HSA-2990846,SUMOylation,M100,1,0
0,1,0,0,-2.8,0,GO:0098926,postsynaptic signal transduction,M010,1,0
1,0,0,-2.1,0,0,GO:0045685,regulation of glial cell differentiation,M100,1,0
1,0,0,-2.8,0,0,WP1559,Transcription factors regulate miRNAs related to cardiac hypertrophy,M100,1,0
0,1,0,0,-2.4,0,GO:0070486,leukocyte aggregation,M010,1,0
1,0,0,-3,0,0,GO:0010633,negative regulation of epithelial cell migration,M100,1,0
1,0,0,-2.5,0,0,GO:0007368,determination of left/right symmetry,M100,1,0
0,1,0,0,-2.1,0,WP5362,TAR syndrome,M010,1,0
0,1,0,0,-2.1,0,M8,PID ENDOTHELIN PATHWAY,M010,1,0
1,0,0,-2.4,0,0,hsa04261,Adrenergic signaling in cardiomyocytes,M100,1,0
1,0,0,-2.1,0,0,GO:2000738,positive regulation of stem cell differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:0070101,positive regulation of chemokine-mediated signaling pathway,M100,1,0
0,1,0,0,-3.3,0,GO:0019932,second-messenger-mediated signaling,M010,1,0
1,0,0,-2.2,0,0,GO:0071322,cellular response to carbohydrate stimulus,M100,1,0
1,0,0,-4.3,0,0,R-HSA-2172127,DAP12 interactions,M100,1,0
0,0,1,0,0,-2.3,WP3888,VEGFA VEGFR2 signaling,M001,1,0
0,0,1,0,0,-2.2,R-HSA-525793,Myogenesis,M001,1,0
0,0,1,0,0,-2.2,hsa05132,Salmonella infection,M001,1,0
0,1,0,0,-2.9,0,GO:0071216,cellular response to biotic stimulus,M010,1,0
1,0,0,-2.1,0,0,GO:0014898,cardiac muscle hypertrophy in response to stress,M100,1,0
0,0,1,0,0,-2.9,GO:0050869,negative regulation of B cell activation,M001,1,0
0,1,0,0,-2.1,0,GO:0060074,synapse maturation,M010,1,0
0,1,0,0,-2.7,0,GO:0045070,positive regulation of viral genome replication,M010,1,0
0,1,0,0,-2.7,0,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,M010,1,0
1,0,0,-2.3,0,0,GO:0048703,embryonic viscerocranium morphogenesis,M100,1,0
0,1,0,0,-2.4,0,GO:0030540,female genitalia development,M010,1,0
0,1,0,0,-2.5,0,GO:0010812,negative regulation of cell-substrate adhesion,M010,1,0
1,0,0,-2.4,0,0,R-HSA-9675126,Diseases of mitotic cell cycle,M100,1,0
0,1,0,0,-2.6,0,GO:0006306,DNA methylation,M010,1,0
0,1,0,0,-2.3,0,GO:2000737,negative regulation of stem cell differentiation,M010,1,0
1,0,0,-3.6,0,0,GO:0010660,regulation of muscle cell apoptotic process,M100,1,0
1,0,0,-2.2,0,0,hsa04144,Endocytosis,M100,1,0
0,0,1,0,0,-2.3,R-HSA-8949275,RUNX3 Regulates Immune Response and Cell Migration,M001,1,0
1,0,0,-2.2,0,0,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,M100,1,0
0,0,1,0,0,-2.9,GO:0021515,cell differentiation in spinal cord,M001,1,0
1,0,0,-2.1,0,0,GO:0071226,cellular response to molecule of fungal origin,M100,1,0
0,1,0,0,-2.7,0,GO:0043405,regulation of MAP kinase activity,M010,1,0
1,0,0,-2.3,0,0,R-HSA-2559585,Oncogene Induced Senescence,M100,1,0
1,0,0,-4.4,0,0,GO:0043401,steroid hormone mediated signaling pathway,M100,1,0
0,1,0,0,-2.1,0,GO:0010453,regulation of cell fate commitment,M010,1,0
0,0,1,0,0,-2.7,GO:0018108,peptidyl-tyrosine phosphorylation,M001,1,0
1,0,0,-5.8,0,0,hsa04218,Cellular senescence,M100,1,0
1,0,0,-4.5,0,0,WP1591,Heart development,M100,1,0
0,0,1,0,0,-2.2,GO:0021517,ventral spinal cord development,M001,1,0
0,0,1,0,0,-2,GO:0051966,"regulation of synaptic transmission, glutamatergic",M001,1,0
0,1,0,0,-4.5,0,GO:0007409,axonogenesis,M010,1,0
1,0,0,-2.1,0,0,GO:0032808,lacrimal gland development,M100,1,0
1,0,0,-2.1,0,0,R-HSA-1989781,PPARA activates gene expression,M100,1,0
0,0,1,0,0,-3.5,M34,PID TCR PATHWAY,M001,1,0
0,0,1,0,0,-2.3,R-HSA-1296072,Voltage gated Potassium channels,M001,1,0
0,1,0,0,-2.4,0,GO:1902284,neuron projection extension involved in neuron projection guidance,M010,1,0
0,1,0,0,-2,0,hsa05030,Cocaine addiction,M010,1,0
1,0,0,-2.3,0,0,GO:0030878,thyroid gland development,M100,1,0
1,0,0,-4.4,0,0,R-HSA-112315,Transmission across Chemical Synapses,M100,1,0
0,1,0,0,-2.3,0,GO:0030166,proteoglycan biosynthetic process,M010,1,0
0,1,0,0,-2.1,0,WP4542,Leukocyte intrinsic Hippo pathway functions,M010,1,0
1,0,0,-2.2,0,0,WP2884,NRF2 pathway,M100,1,0
1,0,0,-2.3,0,0,hsa04920,Adipocytokine signaling pathway,M100,1,0
0,1,0,0,-2.1,0,GO:0019722,calcium-mediated signaling,M010,1,0
1,0,0,-2.9,0,0,M12,PID RHOA PATHWAY,M100,1,0
0,1,0,0,-2.9,0,hsa05208,Chemical carcinogenesis - reactive oxygen species,M010,1,0
1,0,0,-2.8,0,0,WP3655,Hypothetical craniofacial development pathway,M100,1,0
0,1,0,0,-5.4,0,WP4222,Phosphodiesterases in neuronal function,M010,1,0
1,0,0,-2.7,0,0,R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,M100,1,0
0,0,1,0,0,-3.6,GO:1903707,negative regulation of hemopoiesis,M001,1,0
0,0,1,0,0,-4.6,R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",M001,1,0
0,0,1,0,0,-2.2,GO:0045058,T cell selection,M001,1,0
1,0,0,-2.2,0,0,hsa04310,Wnt signaling pathway,M100,1,0
1,0,0,-2.5,0,0,WP2814,Mammary gland development pathway Puberty Stage 2 of 4,M100,1,0
0,0,1,0,0,-2.4,R-HSA-9680350,Signaling by CSF1 (M-CSF) in myeloid cells,M001,1,0
1,0,0,-2.3,0,0,GO:0002200,somatic diversification of immune receptors,M100,1,0
0,0,1,0,0,-2.7,GO:0007219,Notch signaling pathway,M001,1,0
1,0,0,-2.8,0,0,GO:0030210,heparin biosynthetic process,M100,1,0
0,0,1,0,0,-2.4,GO:0001958,endochondral ossification,M001,1,0
1,0,0,-2.8,0,0,R-HSA-975155,MyD88 dependent cascade initiated on endosome,M100,1,0
1,0,0,-3,0,0,GO:0048608,reproductive structure development,M100,1,0
0,1,0,0,-2.3,0,GO:0061760,antifungal innate immune response,M010,1,0
1,0,0,-2.1,0,0,R-HSA-3642278,Loss of Function of TGFBR2 in Cancer,M100,1,0
0,1,0,0,-2.6,0,GO:0006305,DNA alkylation,M010,1,0
1,0,0,-2.1,0,0,GO:0021843,substrate-independent telencephalic tangential interneuron migration,M100,1,0
0,1,0,0,-2.2,0,GO:0097150,neuronal stem cell population maintenance,M010,1,0
1,0,0,-2.7,0,0,GO:0043616,keratinocyte proliferation,M100,1,0
1,0,0,-2.3,0,0,GO:0051146,striated muscle cell differentiation,M100,1,0
0,1,0,0,-2.1,0,GO:0030865,cortical cytoskeleton organization,M010,1,0
1,0,0,-2.7,0,0,GO:0009791,post-embryonic development,M100,1,0
1,0,0,-2.4,0,0,GO:0002711,positive regulation of T cell mediated immunity,M100,1,0
0,1,0,0,-2.9,0,GO:0060136,embryonic process involved in female pregnancy,M010,1,0
0,1,0,0,-2.1,0,GO:0007249,canonical NF-kappaB signal transduction,M010,1,0
0,1,0,0,-3.1,0,hsa05323,Rheumatoid arthritis,M010,1,0
0,1,0,0,-2.3,0,M233,PID EPO PATHWAY,M010,1,0
0,0,1,0,0,-2,GO:0045620,negative regulation of lymphocyte differentiation,M001,1,0
0,0,1,0,0,-2.3,GO:0048385,regulation of retinoic acid receptor signaling pathway,M001,1,0
0,1,0,0,-2.1,0,GO:2000027,regulation of animal organ morphogenesis,M010,1,0
0,1,0,0,-2.4,0,GO:0002448,mast cell mediated immunity,M010,1,0
0,0,1,0,0,-3.5,GO:0014902,myotube differentiation,M001,1,0
1,0,0,-2.2,0,0,GO:0030308,negative regulation of cell growth,M100,1,0
0,1,0,0,-2.1,0,GO:0021561,facial nerve development,M010,1,0
0,1,0,0,-2.4,0,GO:0008356,asymmetric cell division,M010,1,0
0,1,0,0,-2.2,0,WP3971,OSX and miRNAs in tooth development,M010,1,0
0,1,0,0,-2.1,0,GO:0030203,glycosaminoglycan metabolic process,M010,1,0
1,0,0,-4.8,0,0,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,M100,1,0
0,0,1,0,0,-2.9,GO:0061030,epithelial cell differentiation involved in mammary gland alveolus development,M001,1,0
1,0,0,-2.3,0,0,R-HSA-9013148,CDC42 GTPase cycle,M100,1,0
1,0,0,-2.9,0,0,GO:0007623,circadian rhythm,M100,1,0
1,0,0,-2.8,0,0,WP536,Calcium regulation in cardiac cells,M100,1,0
1,0,0,-2.1,0,0,hsa04925,Aldosterone synthesis and secretion,M100,1,0
0,1,0,0,-2,0,GO:0001738,morphogenesis of a polarized epithelium,M010,1,0
1,0,0,-2.1,0,0,CORUM:6299,ELK1-SAP1a-EWS-FLI-FLI complex,M100,1,0
1,0,0,-2.8,0,0,R-HSA-197264,Nicotinamide salvaging,M100,1,0
1,0,0,-2.8,0,0,GO:0003180,aortic valve morphogenesis,M100,1,0
0,1,0,0,-2.9,0,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,M010,1,0
0,1,0,0,-3.7,0,GO:0060384,innervation,M010,1,0
0,1,0,0,-2.3,0,GO:0008360,regulation of cell shape,M010,1,0
1,0,0,-2.6,0,0,GO:0060575,intestinal epithelial cell differentiation,M100,1,0
1,0,0,-2.8,0,0,GO:0033500,carbohydrate homeostasis,M100,1,0
0,1,0,0,-2.6,0,GO:0040013,negative regulation of locomotion,M010,1,0
0,1,0,0,-2,0,GO:0006879,intracellular iron ion homeostasis,M010,1,0
0,0,1,0,0,-2.2,R-HSA-186763,Downstream signal transduction,M001,1,0
0,1,0,0,-2.1,0,GO:0031099,regeneration,M010,1,0
1,0,0,-3,0,0,GO:0002715,regulation of natural killer cell mediated immunity,M100,1,0
0,1,0,0,-2.3,0,hsa05332,Graft-versus-host disease,M010,1,0
0,0,1,0,0,-2.8,WP364,IL6 signaling pathway,M001,1,0
0,0,1,0,0,-2.6,R-HSA-8939245,RUNX1 regulates transcription of genes involved in BCR signaling,M001,1,0
0,1,0,0,-2.1,0,GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,M010,1,0
0,1,0,0,-2.9,0,GO:1901741,positive regulation of myoblast fusion,M010,1,0
1,0,0,-2.1,0,0,GO:0097028,dendritic cell differentiation,M100,1,0
1,0,0,-3.6,0,0,M288,PID HES HEY PATHWAY,M100,1,0
0,0,1,0,0,-2,R-HSA-4086398,Ca2+ pathway,M001,1,0
0,1,0,0,-2.1,0,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,M010,1,0
1,0,0,-2.6,0,0,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,M100,1,0
0,1,0,0,-3.4,0,GO:0032088,negative regulation of NF-kappaB transcription factor activity,M010,1,0
1,0,0,-2.8,0,0,R-HSA-8866911,TFAP2 (AP-2) family regulates transcription of cell cycle factors,M100,1,0
1,0,0,-2.1,0,0,GO:0048382,mesendoderm development,M100,1,0
0,1,0,0,-3.2,0,GO:0001829,trophectodermal cell differentiation,M010,1,0
0,1,0,0,-4.2,0,M45,PID CD40 PATHWAY,M010,1,0
0,0,1,0,0,-3.2,GO:0048665,neuron fate specification,M001,1,0
0,1,0,0,-2.1,0,M144,PID CERAMIDE PATHWAY,M010,1,0
0,1,0,0,-2.1,0,GO:0060688,regulation of morphogenesis of a branching structure,M010,1,0
1,0,0,-2.8,0,0,GO:0045778,positive regulation of ossification,M100,1,0
1,0,0,-2.4,0,0,GO:0009749,response to glucose,M100,1,0
1,0,0,-2.1,0,0,GO:0090207,regulation of triglyceride metabolic process,M100,1,0
0,1,0,0,-2.2,0,hsa04672,Intestinal immune network for IgA production,M010,1,0
0,1,0,0,-2,0,GO:0002275,myeloid cell activation involved in immune response,M010,1,0
1,0,0,-2.7,0,0,GO:0035282,segmentation,M100,1,0
0,1,0,0,-2.2,0,GO:0036302,atrioventricular canal development,M010,1,0
0,1,0,0,-2,0,R-HSA-3214841,PKMTs methylate histone lysines,M010,1,0
1,0,0,-2.5,0,0,hsa05414,Dilated cardiomyopathy,M100,1,0
1,0,0,-2.8,0,0,GO:0035905,ascending aorta development,M100,1,0
1,0,0,-2.4,0,0,GO:0010664,negative regulation of striated muscle cell apoptotic process,M100,1,0
1,0,0,-2.8,0,0,GO:0010656,negative regulation of muscle cell apoptotic process,M100,1,0
0,1,0,0,-2,0,GO:0002444,myeloid leukocyte mediated immunity,M010,1,0
0,1,0,0,-2.5,0,GO:0001953,negative regulation of cell-matrix adhesion,M010,1,0
1,0,0,-2.2,0,0,WP5422,IL 19 signaling pathway map,M100,1,0
1,0,0,-2.1,0,0,R-HSA-8849473,PTK6 Expression,M100,1,0
0,0,1,0,0,-2.6,GO:0048857,neural nucleus development,M001,1,0
0,0,1,0,0,-2.1,M193,PID NEPHRIN NEPH1 PATHWAY,M001,1,0
0,0,1,0,0,-3.4,GO:0050853,B cell receptor signaling pathway,M001,1,0
1,0,0,-2,0,0,GO:0042752,regulation of circadian rhythm,M100,1,0
0,1,0,0,-2.9,0,GO:0071699,olfactory placode morphogenesis,M010,1,0
0,1,0,0,-3.6,0,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,M010,1,0
0,1,0,0,-2.3,0,CORUM:1054,ESR1-RELA-BCL3-NCOA3 complex,M010,1,0
0,0,1,0,0,-3.1,GO:0060216,definitive hemopoiesis,M001,1,0
0,1,0,0,-2.7,0,R-HSA-9637628,Modulation by Mtb of host immune system,M010,1,0
1,0,0,-6.5,0,0,GO:0048384,retinoic acid receptor signaling pathway,M100,1,0
1,0,0,-3.2,0,0,GO:0032922,circadian regulation of gene expression,M100,1,0
0,1,0,0,-2.8,0,hsa05120,Epithelial cell signaling in Helicobacter pylori infection,M010,1,0
1,0,0,-4.2,0,0,WP5397,Vitamin A1 and A5 X pathways,M100,1,0
0,1,0,0,-2,0,hsa04917,Prolactin signaling pathway,M010,1,0
0,0,1,0,0,-2,R-HSA-8943724,Regulation of PTEN gene transcription,M001,1,0
0,0,1,0,0,-2.6,hsa04514,Cell adhesion molecules,M001,1,0
0,1,0,0,-2.2,0,hsa04670,Leukocyte transendothelial migration,M010,1,0
0,1,0,0,-2.6,0,GO:0042474,middle ear morphogenesis,M010,1,0
0,0,1,0,0,-3.4,GO:0045577,regulation of B cell differentiation,M001,1,0
0,1,0,0,-2.6,0,GO:0050900,leukocyte migration,M010,1,0
0,1,0,0,-2.6,0,GO:0032930,positive regulation of superoxide anion generation,M010,1,0
0,0,1,0,0,-2,WP4823,Genes controlling nephrogenesis,M001,1,0
0,1,0,0,-2.8,0,GO:0060191,regulation of lipase activity,M010,1,0
1,0,0,-2.8,0,0,GO:1905314,semi-lunar valve development,M100,1,0
1,0,0,-2.3,0,0,R-HSA-5576891,Cardiac conduction,M100,1,0
1,0,0,-2.1,0,0,GO:1990928,response to amino acid starvation,M100,1,0
0,0,1,0,0,-2.1,GO:0031589,cell-substrate adhesion,M001,1,0
1,0,0,-2.6,0,0,hsa04727,GABAergic synapse,M100,1,0
1,0,0,-6,0,0,WP4674,Head and neck squamous cell carcinoma,M100,1,0
0,0,1,0,0,-2.6,R-HSA-8877330,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),M001,1,0
1,0,0,-2.1,0,0,GO:0097193,intrinsic apoptotic signaling pathway,M100,1,0
0,1,0,0,-4.4,0,WP4141,PI3K AKT mTOR vitamin D3 signaling,M010,1,0
1,0,0,-2.4,0,0,GO:0045687,positive regulation of glial cell differentiation,M100,1,0
1,0,0,-3.1,0,0,GO:0030278,regulation of ossification,M100,1,0
0,1,0,0,-3.3,0,WP2873,Aryl hydrocarbon receptor pathway,M010,1,0
0,1,0,0,-2.1,0,GO:0019935,cyclic-nucleotide-mediated signaling,M010,1,0
0,0,1,0,0,-2.3,GO:0014016,neuroblast differentiation,M001,1,0
1,0,0,-2.8,0,0,GO:0071499,cellular response to laminar fluid shear stress,M100,1,0
0,1,0,0,-2.9,0,GO:1902869,regulation of amacrine cell differentiation,M010,1,0
0,1,0,0,-4,0,GO:0048339,paraxial mesoderm development,M010,1,0
0,0,1,0,0,-2.6,GO:0009435,NAD biosynthetic process,M001,1,0
1,0,0,-2.9,0,0,GO:0003179,heart valve morphogenesis,M100,1,0
0,0,1,0,0,-2.2,GO:0048546,digestive tract morphogenesis,M001,1,0
1,0,0,-2.8,0,0,WP2431,Spinal cord injury,M100,1,0
1,0,0,-2.8,0,0,hsa05222,Small cell lung cancer,M100,1,0
1,0,0,-2.7,0,0,GO:0098581,detection of external biotic stimulus,M100,1,0
1,0,0,-3,0,0,GO:0042692,muscle cell differentiation,M100,1,0
1,0,0,-2.8,0,0,GO:0070167,regulation of biomineral tissue development,M100,1,0
0,1,0,0,-3.5,0,GO:0070670,response to interleukin-4,M010,1,0
0,1,0,0,-3,0,GO:0097529,myeloid leukocyte migration,M010,1,0
0,1,0,0,-2.5,0,GO:0035088,establishment or maintenance of apical/basal cell polarity,M010,1,0
1,0,0,-2.1,0,0,CORUM:2084,NFKB1-NFKB2-REL-RELA-RELB complex,M100,1,0
0,1,0,0,-2.3,0,GO:0045859,regulation of protein kinase activity,M010,1,0
0,1,0,0,-2.4,0,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,M010,1,0
0,1,0,0,-2.3,0,WP4582,Cancer immunotherapy by CTLA4 blockade,M010,1,0
1,0,0,-2.4,0,0,WP2263,Androgen receptor network in prostate cancer,M100,1,0
1,0,0,-5.7,0,0,WP5353,A network map of Macrophage stimulating protein MSP signaling,M100,1,0
0,1,0,0,-2,0,GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,M010,1,0
0,0,1,0,0,-2.6,GO:0019363,pyridine nucleotide biosynthetic process,M001,1,0
0,0,1,0,0,-2.1,GO:0021510,spinal cord development,M001,1,0
0,1,0,0,-2.3,0,GO:0045136,development of secondary sexual characteristics,M010,1,0
1,0,0,-2.1,0,0,GO:2000741,positive regulation of mesenchymal stem cell differentiation,M100,1,0
0,1,0,0,-2.5,0,GO:0071230,cellular response to amino acid stimulus,M010,1,0
0,1,0,0,-3.6,0,WP4217,Ebola virus infection in host,M010,1,0
1,0,0,-4.2,0,0,hsa05212,Pancreatic cancer,M100,1,0
0,1,0,0,-3.1,0,hsa04613,Neutrophil extracellular trap formation,M010,1,0
0,1,0,0,-2.5,0,GO:0001755,neural crest cell migration,M010,1,0
0,0,1,0,0,-2.3,M69,PID REELIN PATHWAY,M001,1,0
0,1,0,0,-2.2,0,GO:0043406,positive regulation of MAP kinase activity,M010,1,0
0,1,0,0,-2.2,0,WP5300,TROP2 regulatory signaling,M010,1,0
0,1,0,0,-3.7,0,GO:0019933,cAMP-mediated signaling,M010,1,0
0,1,0,0,-2,0,GO:0042060,wound healing,M010,1,0
0,1,0,0,-2,0,GO:0030336,negative regulation of cell migration,M010,1,0
1,0,0,-2.8,0,0,GO:0021902,commitment of neuronal cell to specific neuron type in forebrain,M100,1,0
1,0,0,-2.4,0,0,GO:0031346,positive regulation of cell projection organization,M100,1,0
0,1,0,0,-4.1,0,GO:0030510,regulation of BMP signaling pathway,M010,1,0
0,1,0,0,-2.4,0,GO:1901137,carbohydrate derivative biosynthetic process,M010,1,0
